<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/' xmlns:georss='http://www.georss.org/georss' xmlns:gd='http://schemas.google.com/g/2005' xmlns:thr='http://purl.org/syndication/thread/1.0'><id>tag:blogger.com,1999:blog-29058079</id><updated>2012-02-02T08:09:14.424-06:00</updated><category term='DILI'/><category term='mentor'/><category term='CRO'/><category term='cancer'/><category term='podcast'/><category term='pharmavoice'/><category term='partnering'/><category term='patients'/><category term='customer'/><category term='clinical'/><category term='i3'/><category term='solutions'/><category term='leadership'/><category term='safety'/><category term='consumers'/><category term='SSI'/><category term='FCPA'/><category term='assets'/><category term='quintiles'/><category term='limbach'/><category term='iometrics'/><category term='call center'/><category term='patient enrollment'/><category term='anti-bribery'/><category term='PhoneScreen'/><category term='kirk'/><category term='brasil'/><category term='emerging'/><category term='mentoring'/><category term='Aravo'/><category term='speed'/><category term='ROI'/><category term='oncology'/><category term='AMAC'/><category term='security'/><category term='HBA'/><category term='capital'/><category term='mapping'/><category term='biotech'/><category term='patient recruitment'/><category term='supply'/><category term='brazil'/><category term='Oncolytics'/><category term='pharma'/><category term='key opinion leader'/><category term='contract research'/><category term='KOL'/><category term='voice biometrics'/><category term='insights'/><category term='drug development'/><category term='hagen'/><category term='optimization'/><category term='compliance'/><category term='drug induced liver injury'/><category term='standard of care'/><category term='global clinical trials'/><category term='tele-detailing'/><category term='social media'/><category term='markets'/><category term='partner'/><category term='accrual'/><category term='itunes'/><category term='advantage'/><category term='inflence'/><title type='text'>PharmaVOICE Podcasts</title><subtitle type='html'>PharmaVOICE interviews movers and shakers from the life sciences. We'll bring you interviews with executives from pharma and biotech as well as service providers to give you interesting stories from across the life sciences spectrum. It's all part of our mission to deliver a glimpse into the people who are forging the present and future of our industry.</subtitle><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/posts/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default?max-results=100'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/'/><link rel='hub' href='http://pubsubhubbub.appspot.com/'/><link rel='next' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default?start-index=101&amp;max-results=100'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>168</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>100</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-29058079.post-7076213436748887541</id><published>2012-02-02T08:09:00.000-06:00</published><updated>2012-02-02T08:09:14.434-06:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='DILI'/><category scheme='http://www.blogger.com/atom/ns#' term='drug induced liver injury'/><title type='text'>Understanding the Impact of Drug Induced Liver Injury on Drug Development</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt; 1/30/2012&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt; 10.3MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:22:36&lt;br /&gt;&lt;b&gt;Thought Leader:&lt;/b&gt;&amp;nbsp;Steve Lobel, PhD, D-ABMLI, MBA, FACB, Vice-president Global Laboratory Operations, PPD&lt;br /&gt;&lt;br /&gt;In this episode, Dr. Lobel talks about Drug-induced liver injury, also known as DILI. We'll cover what DILI is, how it is identified, and its effects on the clinical development process. At the end of this podcast, you'll learn where you can download a related white paper on this topic.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/webcasts/0112PPD/2012-01-podcast-ppd.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-7076213436748887541?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/7076213436748887541/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=7076213436748887541' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/7076213436748887541'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/7076213436748887541'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2012/02/understanding-impact-of-drug-induced.html' title='Understanding the Impact of Drug Induced Liver Injury on Drug Development'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/14337989467289249751</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-3876733408246128365</id><published>2012-02-02T08:05:00.000-06:00</published><updated>2012-02-02T08:05:59.826-06:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='social media'/><title type='text'>The Evolving Social Media Lifecycle in Pharma</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt; 1/30/2012&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt; 6.04MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:13:12&lt;br /&gt;&lt;b&gt;Thought Leaders:&lt;/b&gt;&amp;nbsp;Nagaraja Srivatsan, Dileep Srinivasan, and Alexander Gochtovtt, Cognizant&lt;br /&gt;&lt;br /&gt;In this episode, a trio of experts from Cognizant talk about numerous issues involving social media in the life sciences. There is also a related white paper you may download.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/webcasts/0112Cognizant/2012-01-podcast-cognizant.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-3876733408246128365?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/3876733408246128365/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=3876733408246128365' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/3876733408246128365'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/3876733408246128365'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2012/02/evolving-social-media-lifecycle-in.html' title='The Evolving Social Media Lifecycle in Pharma'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/14337989467289249751</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-6940695208481162519</id><published>2012-02-02T08:03:00.000-06:00</published><updated>2012-02-02T08:03:43.335-06:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='patient enrollment'/><category scheme='http://www.blogger.com/atom/ns#' term='CRO'/><category scheme='http://www.blogger.com/atom/ns#' term='contract research'/><title type='text'>How the New Role of the CRO Affects Patient Enrollment</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt; 1/30/2012&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt; 7.66MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:16:44&lt;br /&gt;&lt;b&gt;Thought Leader:&lt;/b&gt;&amp;nbsp;Richard Malcolm, CEO, Acurian&lt;br /&gt;&lt;br /&gt;In this episode, Dr. Malcolm discusses how the role of the CRO is transitioning from commodity service supplier to strategic partner, and the unintended negative consequences this could have on what is already the most expensive part of clinical trials: patient enrollment.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/webcasts/0112Acurian/2012-01-podcast-acurian.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-6940695208481162519?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/6940695208481162519/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=6940695208481162519' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/6940695208481162519'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/6940695208481162519'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2012/02/how-new-role-of-cro-affects-patient.html' title='How the New Role of the CRO Affects Patient Enrollment'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/14337989467289249751</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-203929680128263682</id><published>2012-02-01T17:02:00.000-06:00</published><updated>2012-02-01T17:02:35.795-06:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='leadership'/><category scheme='http://www.blogger.com/atom/ns#' term='oncology'/><category scheme='http://www.blogger.com/atom/ns#' term='cancer'/><title type='text'>Transformative Leadership</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt;&amp;nbsp;12/27/2011&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;10.3MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:22:36&lt;br /&gt;&lt;b&gt;Thought Leader:&lt;/b&gt;&amp;nbsp;Dr. Deborah Dunsire, President and CEO, Millennium: The Takeda Oncology Company&lt;br /&gt;&lt;br /&gt;In this episode, Dr. Dunsire shares her insights on the quest to find a cure for cancer, on women striving for positions in the C-Suite, and thoughts on her own career development and recognition as the 2009 HBA Woman of the Year.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/webcasts/0112Millennium/2012-01-podcast-millennium.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-203929680128263682?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/203929680128263682/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=203929680128263682' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/203929680128263682'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/203929680128263682'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2012/02/transformative-leadership.html' title='Transformative Leadership'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/14337989467289249751</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-1490741237707175156</id><published>2012-01-04T09:01:00.000-06:00</published><updated>2012-01-04T09:01:20.024-06:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='compliance'/><category scheme='http://www.blogger.com/atom/ns#' term='Aravo'/><category scheme='http://www.blogger.com/atom/ns#' term='anti-bribery'/><category scheme='http://www.blogger.com/atom/ns#' term='pharma'/><category scheme='http://www.blogger.com/atom/ns#' term='FCPA'/><title type='text'>Automating Pharma FCPA Due Diligence</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt;&amp;nbsp;12/27/2011&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;8.57MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:18:43&lt;br /&gt;&lt;b&gt;Thought Leader:&lt;/b&gt;&amp;nbsp;Robert Shecterle, Vice President of Marketing, Aravo&lt;br /&gt;&lt;br /&gt;In this episode, Mr. Shecterle discusses FCPA Compliance and anti-bribery practices at large pharmaceutical and life sciences companies.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/webcasts/1211Aravo/2011-12-podcast-aravo.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-1490741237707175156?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/1490741237707175156/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=1490741237707175156' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/1490741237707175156'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/1490741237707175156'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2012/01/automating-pharma-fcpa-due-diligence.html' title='Automating Pharma FCPA Due Diligence'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/14337989467289249751</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-6075142449301623071</id><published>2012-01-04T08:55:00.000-06:00</published><updated>2012-01-04T08:55:25.694-06:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='standard of care'/><category scheme='http://www.blogger.com/atom/ns#' term='patients'/><category scheme='http://www.blogger.com/atom/ns#' term='Oncolytics'/><category scheme='http://www.blogger.com/atom/ns#' term='biotech'/><title type='text'>The C-Suite: How Biotech Improves the Standard of Care of Patients</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt;&amp;nbsp;12/27/2011&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;5.56MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:12:08&lt;br /&gt;&lt;b&gt;Thought Leader:&lt;/b&gt;&amp;nbsp;Brad Thompson, Ph.D., Chairman, President and CEO, Oncolytics Biotech&lt;br /&gt;&lt;br /&gt;In this episode, Dr. Thompson talks about how biotech is making improvements in the standard of care, and the impact of Pharma 3.0. He also talks about his own experience taking REOLYSINÂ® through the drug development process, the genesis of Oncolytics Biotech, and shares some insights for biotech entrepreneurs.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/webcasts/1211Oncolytics/2011-12-podcast-oncolytics.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-6075142449301623071?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/6075142449301623071/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=6075142449301623071' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/6075142449301623071'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/6075142449301623071'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2012/01/c-suite-how-biotech-improves-standard.html' title='The C-Suite: How Biotech Improves the Standard of Care of Patients'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/14337989467289249751</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-359810358591706381</id><published>2012-01-04T08:52:00.000-06:00</published><updated>2012-01-04T08:52:58.909-06:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='consumers'/><category scheme='http://www.blogger.com/atom/ns#' term='social media'/><category scheme='http://www.blogger.com/atom/ns#' term='SSI'/><title type='text'>Understanding How Social Networks Drive Healthcare Decisions: Mapping a New "Influence" Landscape</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt;&amp;nbsp;12/23/2011&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;7.7MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:16:49&lt;br /&gt;&lt;b&gt;Thought Leader:&lt;/b&gt;&amp;nbsp;Chris DeAngelis, Vice President, Strategic Initiatives, SSI&lt;br /&gt;&lt;br /&gt;In this episode, Mr. DeAngelis discusses a variety of issues regarding consumers' usage of social media for healthcare information. You'll learn some of the results of a study of over 1,400 U.S. consumers participating in proprietary panels and web communities.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/webcasts/2011_12_SSI/2011-12-podcast-ssi.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-359810358591706381?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/359810358591706381/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=359810358591706381' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/359810358591706381'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/359810358591706381'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2012/01/understanding-how-social-networks-drive.html' title='Understanding How Social Networks Drive Healthcare Decisions: Mapping a New &quot;Influence&quot; Landscape'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/14337989467289249751</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-3704875472346305667</id><published>2012-01-04T08:50:00.000-06:00</published><updated>2012-01-04T08:50:03.040-06:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='PhoneScreen'/><category scheme='http://www.blogger.com/atom/ns#' term='AMAC'/><category scheme='http://www.blogger.com/atom/ns#' term='tele-detailing'/><title type='text'>Tele-detailing: Responding to Changing Pharma Sales Models</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt;&amp;nbsp;12/23/2011&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;7.55MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:16:30&lt;br /&gt;&lt;b&gt;Thought Leader:&lt;/b&gt;&amp;nbsp;Lou Shapiro, Senior Vice President, AMAC Services Group and the PhoneScreen brand&lt;br /&gt;&lt;br /&gt;In this episode, Mr. Shapiro talks about the challenges life science companies face when providing information on their products to physicians and healthcare providers.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/webcasts/0112PhoneScreen/2011-12-podcast-phonescreen.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-3704875472346305667?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/3704875472346305667/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=3704875472346305667' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/3704875472346305667'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/3704875472346305667'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2012/01/tele-detailing-responding-to-changing.html' title='Tele-detailing: Responding to Changing Pharma Sales Models'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/14337989467289249751</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-340925522423884885</id><published>2012-01-03T16:41:00.000-06:00</published><updated>2012-01-03T16:41:52.562-06:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='patient recruitment'/><category scheme='http://www.blogger.com/atom/ns#' term='patient enrollment'/><title type='text'>Additive Patient Recruitment</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt;&amp;nbsp;11/23/2011&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;7.64MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:16:42&lt;br /&gt;&lt;b&gt;Thought Leader:&lt;/b&gt;&amp;nbsp;Roger Smith, Senior Vice President, Operations, Acurian&lt;br /&gt;&lt;br /&gt;In this episode, Mr. Smith talks about clinical trial enrollment and the concept of Additive Patient Recruitment.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/webcasts/1111Acurian/2011-11-podcast-acurian.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-340925522423884885?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/340925522423884885/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=340925522423884885' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/340925522423884885'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/340925522423884885'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2012/01/additive-patient-recruitment.html' title='Additive Patient Recruitment'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/14337989467289249751</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-4050557125434417195</id><published>2011-11-16T14:32:00.000-06:00</published><updated>2011-11-16T14:32:16.561-06:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='itunes'/><title type='text'>iTunes Cover Art</title><content type='html'>&lt;div class="separator" style="clear: both; text-align: center;"&gt;&lt;a href="http://1.bp.blogspot.com/-JmUfPKLAwI8/TsQdq7_4nXI/AAAAAAAAACQ/hIlavoRj4B0/s1600/itune-cover.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"&gt;&lt;img border="0" hda="true" src="http://1.bp.blogspot.com/-JmUfPKLAwI8/TsQdq7_4nXI/AAAAAAAAACQ/hIlavoRj4B0/s1600/itune-cover.jpg" /&gt;&lt;/a&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-4050557125434417195?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/4050557125434417195/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=4050557125434417195' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/4050557125434417195'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/4050557125434417195'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2011/11/itunes-cover-art.html' title='iTunes Cover Art'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/14337989467289249751</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://1.bp.blogspot.com/-JmUfPKLAwI8/TsQdq7_4nXI/AAAAAAAAACQ/hIlavoRj4B0/s72-c/itune-cover.jpg' height='72' width='72'/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-7633030221353894496</id><published>2011-11-16T13:54:00.000-06:00</published><updated>2011-11-16T13:54:12.522-06:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='patients'/><category scheme='http://www.blogger.com/atom/ns#' term='emerging'/><category scheme='http://www.blogger.com/atom/ns#' term='brazil'/><category scheme='http://www.blogger.com/atom/ns#' term='brasil'/><category scheme='http://www.blogger.com/atom/ns#' term='markets'/><title type='text'>Understanding Patients in the Emerging Market of Brazil</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt;&amp;nbsp;11/10/2011&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;6.89MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:15:03&lt;br /&gt;&lt;b&gt;Thought Leader:&lt;/b&gt;&amp;nbsp;David Pomerantz, Senior Vice President, Business Development, Kantar Health&lt;br /&gt;&lt;br /&gt;In this episode, Mr. Pomerantz talks about the influence of patients in pharma and especially in emerging markets such as Brazil.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/webcasts/1111KantarHealth/2011-10-podcast-kantar-v2.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-7633030221353894496?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/7633030221353894496/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=7633030221353894496' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/7633030221353894496'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/7633030221353894496'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2011/11/understanding-patients-in-emerging.html' title='Understanding Patients in the Emerging Market of Brazil'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/14337989467289249751</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-8956333341127214199</id><published>2011-11-16T13:51:00.000-06:00</published><updated>2011-11-16T13:51:30.558-06:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='global clinical trials'/><category scheme='http://www.blogger.com/atom/ns#' term='emerging'/><category scheme='http://www.blogger.com/atom/ns#' term='markets'/><category scheme='http://www.blogger.com/atom/ns#' term='clinical'/><title type='text'>Planning for Clinical Trial Conduct in Emerging Locations</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt;&amp;nbsp;9/28/2011&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;6.4MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:14:07&lt;br /&gt;&lt;b&gt;Thought Leader:&lt;/b&gt;&amp;nbsp;Kelly Larrabee, RN, MBA, MS, Senior Director, Clinical Services, ClearTrial&lt;br /&gt;&lt;br /&gt;In this episode Ms. Larrabee discusses clinical trials in emerging countries, and the major planning challenges, plus how collaborative partnerships are helping in the search for new treatments. For more information about ClearTrial, visit &lt;a href="http://www.cleartrial.com/"&gt;http://www.cleartrial.com/&lt;/a&gt;.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/webcasts/1011ClearTrial/2011-09-podcast-ClearTrial.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-8956333341127214199?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/8956333341127214199/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=8956333341127214199' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/8956333341127214199'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/8956333341127214199'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2011/11/planning-for-clinical-trial-conduct-in.html' title='Planning for Clinical Trial Conduct in Emerging Locations'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/14337989467289249751</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-5746857101146520464</id><published>2011-11-16T13:49:00.000-06:00</published><updated>2011-11-16T13:49:28.471-06:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pharmavoice'/><category scheme='http://www.blogger.com/atom/ns#' term='partnering'/><category scheme='http://www.blogger.com/atom/ns#' term='partner'/><category scheme='http://www.blogger.com/atom/ns#' term='call center'/><title type='text'>Keys to Partnering with a Pharmaceutical Call Center</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt;&amp;nbsp;9/13/2011&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;4.67MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:10:13&lt;br /&gt;&lt;b&gt;Thought Leader:&lt;/b&gt;&amp;nbsp;Lou Shapiro, Senior Vice President, AMAC Services Group and the PhoneScreen brand&lt;br /&gt;&lt;br /&gt;In this episode, Mr. Shapiro shares his views on how pharmaceutical, biotech, and medical device companies can benefit from partnering with a qualified pharmaceutical call center. For more information about PhoneScreen, visit &lt;a href="http://www.phonescreen.com/"&gt;http://www.phonescreen.com/&lt;/a&gt;.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/webcasts/0911PhoneScreen/2011-09-podcast-PhoneScreen.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-5746857101146520464?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/5746857101146520464/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=5746857101146520464' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/5746857101146520464'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/5746857101146520464'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2011/11/keys-to-partnering-with-pharmaceutical.html' title='Keys to Partnering with a Pharmaceutical Call Center'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/14337989467289249751</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-4544969534130134297</id><published>2011-11-16T13:47:00.000-06:00</published><updated>2011-11-16T13:47:20.697-06:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='customer'/><category scheme='http://www.blogger.com/atom/ns#' term='ROI'/><category scheme='http://www.blogger.com/atom/ns#' term='insights'/><title type='text'>Leveraging Customer Insights to Maximize ROI</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt;&amp;nbsp;8/31/2011&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;6.17MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:13:29&lt;br /&gt;&lt;b&gt;Thought Leaders:&lt;/b&gt;&amp;nbsp;Jay Bolling, President &amp;amp; CEO, Chuck McLeester, SVP Planning, Metrics &amp;amp; Analytics, Kurt Mueller, Chief Digital &amp;amp; Science Officer, Roska Healthcare Advertising&lt;br /&gt;&lt;br /&gt;In this episode, the team at Roska Healthcare discusses new ways to use behavioral and attitudinal data to enhance customer targeting and messaging. They review a unique, new communications model (Catalyst-tm) that increases customer 'acceptance' (engagement) and drives more people to take action.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/webcasts/0811Roska/2011-08-Roska.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-4544969534130134297?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/4544969534130134297/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=4544969534130134297' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/4544969534130134297'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/4544969534130134297'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2011/11/leveraging-customer-insights-to.html' title='Leveraging Customer Insights to Maximize ROI'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/14337989467289249751</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-6734377191289671498</id><published>2011-11-16T13:44:00.000-06:00</published><updated>2011-11-16T13:44:50.348-06:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='mentoring'/><category scheme='http://www.blogger.com/atom/ns#' term='mentor'/><category scheme='http://www.blogger.com/atom/ns#' term='advantage'/><category scheme='http://www.blogger.com/atom/ns#' term='HBA'/><title type='text'>Mentoring: A Professional Advantage</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt;&amp;nbsp;8/12/2011&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;6.17MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:13:29&lt;br /&gt;&lt;b&gt;Thought Leader:&lt;/b&gt;&amp;nbsp;Laurie Cooke, CEO, Healthcare Businesswomen's Association&lt;br /&gt;&lt;br /&gt;In this episode, Ms. Cooke discusses what it means to be honored as Mentor of the Year, why mentoring is an important career development strategy, and the HBA's commitment to helping its members develop their careers through mentoring and coaching.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/webcasts/0811HBA/2011-08-HBA-edit1.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-6734377191289671498?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/6734377191289671498/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=6734377191289671498' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/6734377191289671498'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/6734377191289671498'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2011/11/mentoring-professional-advantage.html' title='Mentoring: A Professional Advantage'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/14337989467289249751</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-920077615260389926</id><published>2011-11-16T13:42:00.000-06:00</published><updated>2011-11-16T13:42:49.272-06:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='inflence'/><category scheme='http://www.blogger.com/atom/ns#' term='key opinion leader'/><category scheme='http://www.blogger.com/atom/ns#' term='mapping'/><category scheme='http://www.blogger.com/atom/ns#' term='KOL'/><title type='text'>Understanding the Power of KOL Influence Mapping</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt;&amp;nbsp;6/27/2011&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;6.37MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:13:55&lt;br /&gt;&lt;b&gt;Thought Leader:&lt;/b&gt;&amp;nbsp;Gary Bartolacci, Senior Account Director, Kantar Health&lt;br /&gt;&lt;br /&gt;In this episode, Mr. Bartolacci discusses the power of key opinion leaders nationally, regionally, and locally. He explains how pharmaceutical companies can achieve stronger results using influence mapping, various approaches to influence mapping (including the benefits and risks of these studies) and best practices, along with addressing clients' most common questions.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/webcasts/0611KantarHealth/2011-06-Kantar-edit1.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-920077615260389926?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/920077615260389926/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=920077615260389926' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/920077615260389926'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/920077615260389926'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2011/11/understanding-power-of-kol-influence.html' title='Understanding the Power of KOL Influence Mapping'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/14337989467289249751</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-6553528214530869929</id><published>2011-11-16T13:40:00.000-06:00</published><updated>2011-11-16T13:40:42.853-06:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='global clinical trials'/><category scheme='http://www.blogger.com/atom/ns#' term='solutions'/><category scheme='http://www.blogger.com/atom/ns#' term='optimization'/><category scheme='http://www.blogger.com/atom/ns#' term='supply'/><title type='text'>Clinical Supply Optimization: Challenges &amp; Solutions</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt;&amp;nbsp;5/31/2011&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;7.8MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:17:03&lt;br /&gt;&lt;b&gt;Thought Leader:&lt;/b&gt;&amp;nbsp;Steven Yoder, Director, Client Services, Fisher Clinical Services&lt;br /&gt;&lt;br /&gt;In this episode, Mr. Yoder discusses the challenges and benefits of clinical supply optimization and what the future looks like as companies strive to achieve a balance between optimization and cost-reduction.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/webcasts/0511Fisher/2011-05-Fisher-edit1.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-6553528214530869929?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/6553528214530869929/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=6553528214530869929' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/6553528214530869929'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/6553528214530869929'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2011/11/clinical-supply-optimization-challenges.html' title='Clinical Supply Optimization: Challenges &amp; Solutions'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/14337989467289249751</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-8768133857216295442</id><published>2011-11-16T13:38:00.000-06:00</published><updated>2011-11-16T13:38:38.059-06:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='capital'/><category scheme='http://www.blogger.com/atom/ns#' term='assets'/><category scheme='http://www.blogger.com/atom/ns#' term='drug development'/><title type='text'>Networked Drug Development - Bringing Assets, Capital and Services Together</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt;&amp;nbsp;5/31/2011&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;5.56MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:12:09&lt;br /&gt;&lt;b&gt;Thought Leader:&lt;/b&gt;&amp;nbsp;Tim Dietlin, VP of Alliance Development, INC Research&lt;br /&gt;&lt;br /&gt;In this episode, Mr. Dietlin discusses a burgeoning concept called the Networked Drug Development Alliance, what it is, what's driving it, and how they improve the process for pharmaceutical companies and investors.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/webcasts/0511INC/2011-05-INC-edit1.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-8768133857216295442?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/8768133857216295442/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=8768133857216295442' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/8768133857216295442'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/8768133857216295442'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2011/11/networked-drug-development-bringing.html' title='Networked Drug Development - Bringing Assets, Capital and Services Together'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/14337989467289249751</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-4310337265877022076</id><published>2011-11-16T13:35:00.000-06:00</published><updated>2011-11-16T13:35:48.393-06:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='speed'/><category scheme='http://www.blogger.com/atom/ns#' term='security'/><category scheme='http://www.blogger.com/atom/ns#' term='safety'/><category scheme='http://www.blogger.com/atom/ns#' term='iometrics'/><category scheme='http://www.blogger.com/atom/ns#' term='voice biometrics'/><title type='text'>Improving Safety, Security, and Speed using Voice Biometrics</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt;&amp;nbsp;4/29/2011&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;7.95MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:17:23&lt;br /&gt;&lt;b&gt;Thought Leader:&lt;/b&gt;&amp;nbsp;Richard Scarbath , Director, Enterprise Accounts, Angel&lt;br /&gt;&lt;br /&gt;In this episode, Mr. Scarbath discusses the movement into voice biometrics for voice signatures and authentication. He provides a general overview of the technology and how it is being applied in the pharmaceutical industry and sampling world..&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/webcasts/0411Angel/2011-04-Angel-edit1.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-4310337265877022076?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/4310337265877022076/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=4310337265877022076' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/4310337265877022076'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/4310337265877022076'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2011/11/improving-safety-security-and-speed.html' title='Improving Safety, Security, and Speed using Voice Biometrics'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/14337989467289249751</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-8171891386049382442</id><published>2011-11-16T13:33:00.000-06:00</published><updated>2011-11-16T13:33:24.408-06:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='global clinical trials'/><title type='text'>The Undercalculated Costs Driving Today's Clinical Trials</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt;&amp;nbsp;4/29/2011&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;12.0MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:26:17&lt;br /&gt;&lt;b&gt;Thought Leader:&lt;/b&gt;&amp;nbsp;Ian Hunter, Global Account Director, Fisher Clinical Services&lt;br /&gt;&lt;br /&gt;In this episode, Mr. Hunter, discusses the many variables and issues surrounding transportation and distribution of product for global clinical trials.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/webcasts/0411Fisher/2011-04-Fisher-edit1.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-8171891386049382442?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/8171891386049382442/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=8171891386049382442' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/8171891386049382442'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/8171891386049382442'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2011/11/undercalculated-costs-driving-todays.html' title='The Undercalculated Costs Driving Today&apos;s Clinical Trials'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/14337989467289249751</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-2209427201518922981</id><published>2011-04-07T17:05:00.002-05:00</published><updated>2011-11-16T13:29:02.190-06:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='accrual'/><category scheme='http://www.blogger.com/atom/ns#' term='oncology'/><title type='text'>Oncology Trials: A Novel Approach to Patient Accrual</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt;&amp;nbsp;3/30/2011&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;5.95MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:13:02&lt;br /&gt;&lt;b&gt;Thought Leader:&lt;/b&gt;&amp;nbsp;Ed Watson, Director of Oncology, Acurian, Inc.&lt;br /&gt;&lt;br /&gt;In this episode, Ed Watson discusses some of the challenges associated with recruiting for clinical studies in oncology, the roles of various key stakeholders, and the sponsor community's response to a new approach to patient accrual.&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;a href="http://www.pharmavoice.com/webcasts/0411Acurian/2011-03-Acurian-edit1.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-2209427201518922981?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/2209427201518922981/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=2209427201518922981' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/2209427201518922981'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/2209427201518922981'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2011/04/oncology-trials-novel-approach-to.html' title='Oncology Trials: A Novel Approach to Patient Accrual'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-3542906276525176203</id><published>2011-04-07T17:04:00.001-05:00</published><updated>2011-04-07T17:06:03.596-05:00</updated><title type='text'>Streamlining Clinical Trials with an Approved Phrase Library for Labeling</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt;&amp;nbsp;3/24/2011&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;7.68MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:16:32&lt;b&gt;Thought Leader:&lt;/b&gt;&amp;nbsp;Kevin Shea, Label Program Director, Clintrak Clinical Labeling Services LLC., a part of Thermo Fisher Scientific&lt;br /&gt;&lt;br /&gt;In this episode, Mr. Shea discusses how clinical trials are affected by label text issues, streamlining the process with a phrase library, and the advantages of managing a phrase library with a dedicated system.&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;a href="http://www.pharmavoice.com/webcasts/0311Clintrak/2011-03-Fisher-edit1.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-3542906276525176203?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/3542906276525176203/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=3542906276525176203' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/3542906276525176203'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/3542906276525176203'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2011/04/streamlining-clinical-trials-with.html' title='Streamlining Clinical Trials with an Approved Phrase Library for Labeling'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-2513213726007252457</id><published>2011-04-07T17:02:00.000-05:00</published><updated>2011-04-07T17:02:18.278-05:00</updated><title type='text'>Why ISMPP?: Leadership, Value, and Best Practices for Medical Publication Professionals</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt;&amp;nbsp;3/4/2011&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;6.78MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:14:49&lt;br /&gt;&lt;b&gt;Thought Leaders:&lt;/b&gt;&amp;nbsp;Kim Goldin, Executive Director, Julia Ralston, President, and Robert Norris, Past President, ISMPP&lt;br /&gt;&lt;br /&gt;In this episode, our thought leaders discuss what ISMPP is and how it's evolved, how the organization can help Medical Publication Professionals, and the 2011 annual meetings in the US in April and in Europe in November.&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;a href="http://www.pharmavoice.com/webcasts/0311ISMPP/2011-02-ISMPP-edit1.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-2513213726007252457?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/2513213726007252457/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=2513213726007252457' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/2513213726007252457'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/2513213726007252457'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2011/04/why-ismpp-leadership-value-and-best.html' title='Why ISMPP?: Leadership, Value, and Best Practices for Medical Publication Professionals'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-1243430581174612956</id><published>2011-04-07T17:00:00.000-05:00</published><updated>2011-04-07T17:00:26.607-05:00</updated><title type='text'>Building a Communications Bridge: A Best Practice for Conducting Clinical Trials in India</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt;&amp;nbsp;3/1/2011&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;7.4MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:16:10&lt;br /&gt;&lt;b&gt;Thought Leaders:&lt;/b&gt;&amp;nbsp;Dr. James A. Bannon, Executive Chairman and Dr. Edward J. Brennan, Jr. President and CEO, IndiPharm&lt;br /&gt;&lt;br /&gt;In this episode, Dr. Bannon and Dr. Brennan discuss conducting clinical trials in India. They cover why a seamless communication strategy is important, how an in-country partner can improve the trial outcome, regulatory issues in India, and the ROI of conducting clinical trials in India.&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;a href="http://www.pharmavoice.com/webcasts/0311IndiPharm/2011-02-IndiPharm-edit1.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-1243430581174612956?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/1243430581174612956/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=1243430581174612956' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/1243430581174612956'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/1243430581174612956'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2011/04/building-communications-bridge-best.html' title='Building a Communications Bridge: A Best Practice for Conducting Clinical Trials in India'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-4393380386339661587</id><published>2011-04-07T16:58:00.000-05:00</published><updated>2011-04-07T16:58:06.468-05:00</updated><title type='text'>A New Wellness-Centric Ecosystem</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt;&amp;nbsp;1/31/2011&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;4.63MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:10:07&lt;br /&gt;&lt;b&gt;Thought Leaders:&lt;/b&gt;&amp;nbsp;Nagaraja Srivatsan, Senior VP and Head of Life Sciences, North America and Dr. Elby Nash, Principal, Cognizant Business Consulting, Life Sciences, Cognizant&lt;br /&gt;&lt;br /&gt;In this episode, Srivatsan and Dr. Nash discuss a forward-thinking business model that focuses on overall patient wellness and preventative medicine rather than simply treating illness.&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;a href="http://www.pharmavoice.com/webcasts/0111Cognizant/2011-01-Cognizant-edit1.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-4393380386339661587?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/4393380386339661587/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=4393380386339661587' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/4393380386339661587'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/4393380386339661587'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2011/04/new-wellness-centric-ecosystem.html' title='A New Wellness-Centric Ecosystem'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-2675214297541007871</id><published>2011-04-07T16:56:00.000-05:00</published><updated>2011-04-07T16:56:25.424-05:00</updated><title type='text'>Best Practices for Your CRO Partnerships</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt;&amp;nbsp;1/31/2011&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;8.04MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:17:34&lt;br /&gt;&lt;b&gt;Thought Leader:&lt;/b&gt;&amp;nbsp;Colin Terry, Executive Vice President, Commercial Operations, Aptuit&lt;br /&gt;&lt;br /&gt;In this episode, Mr. Terry shares his perspective on how drug developers can move beyond the typical, transactional, approach to outsourcing and instead, create true partnerships with their CROs that reflect a commitment to a shared development vision.&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;a href="http://www.pharmavoice.com/webcasts/0111Aptuit/2011-01-Aptuit-edit2.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-2675214297541007871?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/2675214297541007871/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=2675214297541007871' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/2675214297541007871'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/2675214297541007871'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2011/04/best-practices-for-your-cro.html' title='Best Practices for Your CRO Partnerships'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-775189104036720319</id><published>2011-04-07T16:51:00.000-05:00</published><updated>2011-04-07T16:51:48.738-05:00</updated><title type='text'>How Integrated Solutions Can Optimize Clinical Research</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt;&amp;nbsp;1/31/2011&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;5.97MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:13:03&lt;br /&gt;&lt;b&gt;Thought Leader:&lt;/b&gt;&amp;nbsp;James DeSanti, CEO, PharmaVigilant&lt;br /&gt;&lt;br /&gt;In this episode, Mr. DeSanti discusses Integrated Solutions in clinical research. We define the concept, outline how sponsors can utilize it, and finally, we cover the benefits and ROI of an integrated approach.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;a href="http://www.pharmavoice.com/webcasts/0111PharmaVigilant/2011-01-PharmaVigilant-edit1.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-775189104036720319?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/775189104036720319/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=775189104036720319' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/775189104036720319'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/775189104036720319'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2011/04/how-integrated-solutions-can-optimize.html' title='How Integrated Solutions Can Optimize Clinical Research'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-2840650738761974621</id><published>2011-04-07T16:49:00.002-05:00</published><updated>2011-04-08T14:43:00.072-05:00</updated><title type='text'>Unveiling the Potential of the CEE Market</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt;&amp;nbsp;1/31/2011&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;8.78MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:19:11&lt;br /&gt;&lt;b&gt;Thought Leader:&lt;/b&gt;&amp;nbsp;Pali F. Kollath DVM, MBA Regional Director, Central &amp;amp; Eastern Europe and Treatment Value Practice, Kantar Health&lt;br /&gt;&lt;br /&gt;In this episode, Pali F. Kollath discusses Central and Eastern Europe as an emerging market for pharmaceutical companies. You'll learn how large this market is, the benefits of moving into this market, some of the risks and challenges, best practices for setting up operations, and where the market is heading in the future.&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;a href="http://www.pharmavoice.com/webcasts/0111Kantar/2011-1-Kantar-CEE-edit1.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;a href="http://www.pharmalinx.com/kantarhealth_CEE/"&gt;Download transcript and white paper&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-2840650738761974621?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/2840650738761974621/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=2840650738761974621' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/2840650738761974621'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/2840650738761974621'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2011/04/unveiling-potential-of-cee-market.html' title='Unveiling the Potential of the CEE Market'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-2767397322850000622</id><published>2011-01-04T14:35:00.003-06:00</published><updated>2011-04-08T14:29:22.203-05:00</updated><title type='text'>China: An Emerging Market for Cancer Therapeutics</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt;&amp;nbsp;12/30/2010&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;6.12MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:13:48&lt;br /&gt;&lt;b&gt;Thought Leader:&lt;/b&gt;&amp;nbsp;Richard Wagner, Ph.D., Senior Director, Kantar Health&lt;br /&gt;In this episode, Dr. Wagner talks about China as an emerging market for cancer drugs, including the differences between the U.S. and China in terms of access to testing and drugs, as well as differences in healthcare coverage. We'll also discuss some of Kantar's latest research on cancer in China.&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;a href="http://www.pharmavoice.com/webcasts/1210KantarHealth/2010-12-Kantar-China-edit1.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;a href="http://www.pharmalinx.com/kantarhealth_china/"&gt;Download transcript and white paper&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-2767397322850000622?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/2767397322850000622/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=2767397322850000622' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/2767397322850000622'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/2767397322850000622'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2011/01/china-emerging-market-for-cancer.html' title='China: An Emerging Market for Cancer Therapeutics'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-3899011549992615369</id><published>2010-12-27T11:40:00.002-06:00</published><updated>2011-01-04T14:54:41.575-06:00</updated><title type='text'>Improving Clinical Research ROI using Remote Source Document Verification</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt;&amp;nbsp;12/17/2010&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;4.92MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:10:45&lt;br /&gt;&lt;b&gt;Thought Leader:&lt;/b&gt;&amp;nbsp;James DeSanti, CEO, PharmaVigilant&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;In this episode, Mr. DeSanti discusses remote source document verification, also known as rSDV. First we'll define rSDV, and then talk about the benefits, challenges, and the ROI of implementing rSDV, as well as other issues.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/webcasts/1010PharmaVigilant/2010-11-PharmaVigilant-edit1.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-3899011549992615369?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/3899011549992615369/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=3899011549992615369' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/3899011549992615369'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/3899011549992615369'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2010/12/improving-clinical-research-roi-using.html' title='Improving Clinical Research ROI using Remote Source Document Verification'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-7359746900648785450</id><published>2010-11-02T08:51:00.002-05:00</published><updated>2011-01-04T14:54:32.645-06:00</updated><title type='text'>Streamlining Clinical Research with Electronic Trial Master Files</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt;&amp;nbsp;9/30/2010&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;7.93MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:17:19&lt;br /&gt;&lt;b&gt;Thought Leader:&lt;/b&gt;&amp;nbsp;James DeSanti, CEO, PharmaVigilant&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;In this episode, Mr. DeSanti discusses the clinical trials trend of moving to an Electronic Trial Master File platform. He covers the strategic and practical aspects of making the move, and what the payback is for doing so.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/webcasts/1010PharmaVigilant/2010-10-PharmaVigilant-edit1.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-7359746900648785450?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/7359746900648785450/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=7359746900648785450' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/7359746900648785450'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/7359746900648785450'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2010/11/streamlining-clinical-research-with.html' title='Streamlining Clinical Research with Electronic Trial Master Files'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-1700061412261571913</id><published>2010-11-02T08:48:00.002-05:00</published><updated>2011-01-04T14:54:25.038-06:00</updated><title type='text'>An Integrated Approach to Comparator Sourcing and Supply Chain Management Solutions</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt;&amp;nbsp;9/30/2010&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;7.93MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:17:19&lt;br /&gt;&lt;b&gt;Thought Leader:&lt;/b&gt;&amp;nbsp;Dr. Philippe Muller, Managing Director Manufacturing and Comparator Services, Fisher Clinical Services&lt;/div&gt;&lt;div&gt;In this episode, we'll discuss using comparator drugs in clinical trials, and overcoming the issues and challenges of using comparators.&lt;/div&gt;&lt;div&gt;&lt;a href="http://www.pharmavoice.com/webcasts/0910Fisher/2010-10-FCS-edit1.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;a href="http://www.pharmalinx.com/fisher_comparator/"&gt;Download related whitepaper&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-1700061412261571913?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/1700061412261571913/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=1700061412261571913' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/1700061412261571913'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/1700061412261571913'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2010/11/integrated-approach-to-comparator.html' title='An Integrated Approach to Comparator Sourcing and Supply Chain Management Solutions'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-4032677022554063848</id><published>2010-11-02T08:45:00.003-05:00</published><updated>2011-01-04T14:53:59.707-06:00</updated><title type='text'>Moving Medical Affairs to the Cloud Proves to be a Very Down-to-Earth Strategy for AstraZeneca</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt;&amp;nbsp;9/24/2010&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;6.22MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:13:35&lt;br /&gt;&lt;b&gt;Thought Leaders:&lt;/b&gt;&amp;nbsp;John Pelkowski, Senior Director of Client Engagement for Medical Affairs, AstraZeneca and Kevin Krause, Senior Director of Medical Affairs, Strategy &amp;amp; Operations, AstraZeneca&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;In this episode, we'll discuss AstraZeneca's recent move to the cloud. The company switched from an on-premise, custom-developed CRM system to Veeva Systems' multi-tenant SaaS CRM system.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;a href="http://www.pharmavoice.com/webcasts/0910Veeva/2010-09-Veeva-AZ-edit2.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-4032677022554063848?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/4032677022554063848/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=4032677022554063848' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/4032677022554063848'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/4032677022554063848'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2010/11/moving-medical-affairs-to-cloud-proves.html' title='Moving Medical Affairs to the Cloud Proves to be a Very Down-to-Earth Strategy for AstraZeneca'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-6869610294661535084</id><published>2010-11-01T16:12:00.003-05:00</published><updated>2011-01-04T14:55:28.623-06:00</updated><title type='text'>Best Practices for Sites and CRO Collaboration</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt;&amp;nbsp;07/29/2010&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;6.64MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:14:31&lt;br /&gt;&lt;b&gt;Thought Leaders:&lt;/b&gt;&amp;nbsp;Ed Jahn, Clinical Operations Specialist, Criterium and Jaime Campbell Hudak, Clinical Data Liaison II, Criterium&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;In this episode, our thought leaders discuss ways for CROs and sites to work together to achieve the best possible results. This episode is chock full of best practices and tips, as well as an overview of the results of a July 2010 survey of sites.&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;a href="http://www.pharmavoice.com/webcasts/0810Criterium/2010-07-criterium-edit1.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-6869610294661535084?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/6869610294661535084/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=6869610294661535084' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/6869610294661535084'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/6869610294661535084'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2010/11/best-practices-for-sites-and-cro.html' title='Best Practices for Sites and CRO Collaboration'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-5283475348372583875</id><published>2010-06-03T08:02:00.000-05:00</published><updated>2010-06-03T08:02:13.776-05:00</updated><title type='text'>The Global Strategic Partner Model as a Key Enabler in Clinical Transformation</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt;&amp;nbsp;6/1/2010&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;5.5MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:11:59&lt;br /&gt;&lt;b&gt;Thought Leaders:&lt;/b&gt;&amp;nbsp;Nagaraja Srivatsan, Vice President, Head of Life Sciences, North America, Cognizant, Ramana Reddy, Practice Leader Life Sciences, Cognizant Business Consulting, Krishnan Rajagopalan Ph.D., Global Head of Life Sciences BPO, Cognizant&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;In this episode, we'll discuss the current state of R&amp;amp;D in the pharmaceutical industry, the ongoing transformation of clinical operations and how the global strategic partner model is facilitating many of these changes.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;a href="http://www.pharmavoice.com/xmlfiles/js/forcedownload.php?file=http://www.pharmavoice.com/webcasts/0610Cognizant/2010-06-cognizant-edit1.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/GSP"&gt;Download Whitepaper&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/GSP"&gt;Download Transcript&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-5283475348372583875?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/5283475348372583875/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=5283475348372583875' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/5283475348372583875'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/5283475348372583875'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2010/06/global-strategic-partner-model-as-key.html' title='The Global Strategic Partner Model as a Key Enabler in Clinical Transformation'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-8987819812791426702</id><published>2010-06-03T07:58:00.000-05:00</published><updated>2010-06-03T07:58:32.722-05:00</updated><title type='text'>Understanding Cloud Computing for CRM</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt;&amp;nbsp;6/1/2010&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;6.47MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:14:09&lt;br /&gt;&lt;b&gt;Thought Leader:&lt;/b&gt;&amp;nbsp;Matt Wallach, Executive VP and General Manager, Veeva Systems&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;In this episode, Mr. Wallach discusses how pharmaceutical companies can benefit from Software as a Service and Cloud Computing to improve the sales process within the life-sciences industry.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;a href="http://www.pharmavoice.com/xmlfiles/js/forcedownload.php?file=http://www.pharmavoice.com/webcasts/0610Veeva/2010-06-veeva-edit2.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;a href="http://www.pharmalinx.com/veeva_cloud/"&gt;Download Transcript&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-8987819812791426702?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/8987819812791426702/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=8987819812791426702' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/8987819812791426702'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/8987819812791426702'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2010/06/understanding-cloud-computing-for-crm.html' title='Understanding Cloud Computing for CRM'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-1736516207782843402</id><published>2010-05-26T09:06:00.000-05:00</published><updated>2010-05-26T09:06:30.482-05:00</updated><title type='text'>U.S. and Global Information Security Standards in Patient Recruitment</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt;&amp;nbsp;05/17/2010&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;4.1MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:8:58&lt;br /&gt;&lt;b&gt;Thought Leader:&lt;/b&gt;&amp;nbsp;Roger Smith, Senior VP, Operations, Acurian Inc.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;In this episode, Mr. Smith provides detailed information related to security standards in patient recruitment, what clinical teams need to consider when selecting the right recruitment partner, and how to navigate and understand the complex guidelines and regulations in this space.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;a href="http://www.pharmavoice.com/xmlfiles/js/forcedownload.php?file=http://www.pharmavoice.com/webcasts/0510Acurian/2010-05-acurian-edit1.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/datasecuritywhitepaper"&gt;Download Whitepaper&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-1736516207782843402?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/1736516207782843402/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=1736516207782843402' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/1736516207782843402'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/1736516207782843402'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2010/05/us-and-global-information-security.html' title='U.S. and Global Information Security Standards in Patient Recruitment'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-6478132420378545363</id><published>2010-05-26T09:03:00.000-05:00</published><updated>2010-05-26T09:03:14.690-05:00</updated><title type='text'>Clinical Delivery Alliances in Drug Development</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt;&amp;nbsp;05/11/2010&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;6.88MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:15:02&lt;br /&gt;&lt;b&gt;Thought Leader:&lt;/b&gt;&amp;nbsp;Tim Dietlin, VP of Alliance Development, INC Research&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;In this episode Mr. Dietlin talks about Clinical Delivery Alliances; what they are and how they can benefit the drug development process.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;a href="http://www.pharmavoice.com/xmlfiles/js/forcedownload.php?file=http://www.pharmavoice.com/webcasts/0510INCResearch/2010-05-INC-edit1.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/cdawhitepaper"&gt;Download Whitepaper&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-6478132420378545363?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/6478132420378545363/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=6478132420378545363' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/6478132420378545363'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/6478132420378545363'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2010/05/clinical-delivery-alliances-in-drug.html' title='Clinical Delivery Alliances in Drug Development'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-629890158355129825</id><published>2010-05-26T09:00:00.001-05:00</published><updated>2010-05-26T09:00:51.549-05:00</updated><title type='text'>Industry Experts Weigh in on Marketing Research after PMRG</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt;&amp;nbsp;05/1/2010&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;10.9MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:23:55&lt;br /&gt;&lt;b&gt;Thought Leaders:&lt;/b&gt;&amp;nbsp;Debbie Kossman, Senior VP, National Analysts Worldwide, and the 2010 President of PMRG, Juliana Mastroserio, Director or Marketing Research, Johnson &amp;amp; Johnson, Lynnette Cooke, CEO, Kantar Health&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;In this episode we'll cover various topics pertaining to marketing research in the pharmaceutical industry. We have three distinguished thought leaders who represent different perspectives on marketing research, and offer some takeways from the 2010 PMRG Annual Conference.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;a href="http://www.pharmavoice.com/xmlfiles/js/forcedownload.php?file=http://www.pharmavoice.com/webcasts/0510PMRG/2010-05-PMRG-edit1.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-629890158355129825?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/629890158355129825/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=629890158355129825' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/629890158355129825'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/629890158355129825'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2010/05/industry-experts-weigh-in-on-marketing.html' title='Industry Experts Weigh in on Marketing Research after PMRG'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-6787532530494308380</id><published>2010-04-08T08:56:00.006-05:00</published><updated>2010-05-26T09:07:26.869-05:00</updated><title type='text'>Leveraging Expanded Access and Named-Patient Programs: Best Practices for Small and Emerging Biotech and Pharma Companies</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt;&amp;nbsp;03/31/2010&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;6.64MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:14:32&lt;br /&gt;&lt;b&gt;Thought Leader:&lt;/b&gt;&amp;nbsp;Nicky Wisener, Biopharmaceutical Account Manager, Idis&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;In this episode, Ms. Wisener describes how expanded access and named-patient programs can help successfully meet patients' needs while addressing the unique challenges faced by smaller and emerging companies.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;a href="http://www.pharmavoice.com/xmlfiles/js/forcedownload.php?file=http://www.pharmavoice.com/webcasts/0310IDIS/2010-04-IDIS-edit1-.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;a href="http://www.pharmalinx.com/idis_named-patient/"&gt;Download Whitepaper&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&amp;nbsp;&lt;/div&gt;&lt;div&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-6787532530494308380?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/6787532530494308380/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=6787532530494308380' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/6787532530494308380'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/6787532530494308380'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2010/04/leveraging-expanded-access-and-named.html' title='Leveraging Expanded Access and Named-Patient Programs: Best Practices for Small and Emerging Biotech and Pharma Companies'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-594745807133282418</id><published>2010-04-08T08:53:00.000-05:00</published><updated>2010-04-08T08:53:20.395-05:00</updated><title type='text'>Brand Stewardship: Best Practices for Maintaining Creative Integrity and Client Services</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date  Posted:&lt;/b&gt;&amp;nbsp;03/29/2010&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;8.40MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:18:21&lt;br /&gt;&lt;b&gt;Thought  Leaders:&lt;/b&gt;&amp;nbsp;Tammy Fischer, President, GSW Worldwide in New York and Bruce Rooke, Chief Creative Officer, GSW Worldwide&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;In this episode, Ms. Fischer and Mr. Rooke discuss best practices for brand stewardship and how to maintain creative integrity. They cover the issues as they relate to the client, the consumer, and the agency.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;a href="http://www.pharmavoice.com/xmlfiles/js/forcedownload.php?file=http://www.pharmavoice.com/webcasts/0310GSW/2010-04-GSW-inVentiv-edit1.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-594745807133282418?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/594745807133282418/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=594745807133282418' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/594745807133282418'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/594745807133282418'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2010/04/brand-stewardship-best-practices-for.html' title='Brand Stewardship: Best Practices for Maintaining Creative Integrity and Client Services'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-8564779469721174151</id><published>2010-04-08T08:50:00.001-05:00</published><updated>2010-05-26T09:08:08.368-05:00</updated><title type='text'>Social Networking for Patient Recruitment for Clinical Trials</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date Posted:&lt;/b&gt;&amp;nbsp;03/18/2010&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;5.77MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:12:36&lt;br /&gt;&lt;b&gt;Thought Leader:&lt;/b&gt;&amp;nbsp;Scott Connor, VP of Marketing, Acurian&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;In this episode, Mr. Connor describes how social networking can be used as a powerful business tool for patient recruitment for clinical trials.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;a href="http://www.pharmavoice.com/xmlfiles/js/forcedownload.php?file=http://www.pharmavoice.com/webcasts/0310Acurian/2010-04-Acurian-edit1.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;a href="http://www.pharmalinx.com/socialrecruiting/"&gt;Download Whitepaper&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&amp;nbsp;&lt;/div&gt;&lt;div&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-8564779469721174151?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/8564779469721174151/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=8564779469721174151' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/8564779469721174151'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/8564779469721174151'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2010/04/social-networking-for-patient.html' title='Social Networking for Patient Recruitment for Clinical Trials'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-1854002002905653540</id><published>2010-04-08T08:48:00.000-05:00</published><updated>2010-04-08T08:48:12.955-05:00</updated><title type='text'>Modernizing Incentive Compensation Plans</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date  Posted:&lt;/b&gt;&amp;nbsp;03/16/2010&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;7.46MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:16:19&lt;br /&gt;&lt;b&gt;Thought  Leader:&lt;/b&gt;&amp;nbsp;Stephen M. Fox, Global Practice Leader, Sales Performance Center of Excellence, IMS Management Consulting&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;In this episode, Mr. Fox discusses incentive compensation plans in the pharmaceutical industry, why the incumbent plans aren't working, and how new solutions have emerged that improve the accuracy and efficiency of plans.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;a href="http://www.pharmavoice.com/xmlfiles/js/forcedownload.php?file=http://www.pharmavoice.com/webcasts/0310IMS/2010-04-IMS-edit1.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-1854002002905653540?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/1854002002905653540/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=1854002002905653540' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/1854002002905653540'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/1854002002905653540'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2010/04/modernizing-incentive-compensation.html' title='Modernizing Incentive Compensation Plans'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-3640518642879529943</id><published>2010-04-08T08:37:00.008-05:00</published><updated>2010-04-08T08:44:42.736-05:00</updated><title type='text'>Standards for Industry-Sponsored Studies and Journal Publication Planning</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date  Posted:&lt;/b&gt;&amp;nbsp;03/12/2010&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;6.53MB&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:14:16&lt;br /&gt;&lt;b&gt;Thought  Leaders:&lt;/b&gt;&amp;nbsp;Bernadette Mansi, Scientific Communications Strategy Head, Cardiovascular, Metabolism and Ophthalmology, GlaxoSmithKline, and Dr. Trish Groves, Deputy Editor, British Medical Journal&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;In this episode we cover the Medical Publishing Insights and Practices (MPIP) initiative, a relatively new development co-sponsored by Amgen, AstraZeneca, GlaxoSmithKline, Pfizer and the International Society for Medical Publication Professionals (ISMPP). Ms. Mansi and Dr. Groves discuss what MPIP is, who is behind the initiative, its goals and accomplishments, and how the pharmaceutical industry and journal editors and publishers are benefitting from collaboration on standards to elevate trust and transparency in publishing industry-sponsored studies. The latest undertaking is the creation of an Authors' Submission Toolkit: A Practical Guide to Getting Your Research Published, being rolled-out at the 6th Annual Meeting of ISMPP, April 19-21, Arlington, VA. To learn more and register, please visit http://www.ismpp.org.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;a href="http://www.pharmavoice.com/xmlfiles/js/forcedownload.php?file=http://www.pharmavoice.com/webcasts/0310ISMPP/2010-04-ISMPP-edit1.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-3640518642879529943?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/3640518642879529943/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=3640518642879529943' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/3640518642879529943'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/3640518642879529943'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2010/04/standards-for-industry-sponsored.html' title='Standards for Industry-Sponsored Studies and Journal Publication Planning'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-6777991372387391418</id><published>2010-03-02T08:19:00.002-06:00</published><updated>2010-03-02T08:26:01.236-06:00</updated><title type='text'>Commercial Compliance for Pharmaceutical and Medical Device Companies</title><content type='html'>&lt;div&gt;&lt;div&gt;&lt;b&gt;Date  Posted:&lt;/b&gt;&amp;nbsp;02/22/2010&amp;nbsp;&lt;br /&gt;&lt;b&gt;Size:&lt;/b&gt;&amp;nbsp;5.62MB&amp;nbsp;&lt;br /&gt;&lt;b&gt;Length:&lt;/b&gt;&amp;nbsp;00:12:17&amp;nbsp;&lt;br /&gt;&lt;b&gt;Thought  Leader:&lt;/b&gt;&amp;nbsp;Daniel Garen, Chief Compliance Officer and Senior Counsel, Siemens  Healthcare Sector, USA&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;In an exclusive interview with PharmaVOICE, Mr. Garen shares his expertise and insights on a variety of commercial compliance issues, including The Sunshine Act, Healthcare Reform, the Foreign Corrupt Practices Act (FCPA), and how companies can create a culture of compliance through proactivity. Mr. Garen is also the keynote speaker at the upcoming Marcus Evans' Commercial Compliance for Pharmaceutical and Medical Device Companies Conference, April 12-13, Washington, D.C. For more information about the conference, please go to: http://www.marcusevansch.com/commericalcompliance.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;a href="http://www.pharmavoice.com/xmlfiles/js/forcedownload.php?file=http://www.pharmavoice.com/webcasts/0210MarcusEvans/0210-MarcusEvans-Garen-edit1.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-6777991372387391418?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/6777991372387391418/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=6777991372387391418' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/6777991372387391418'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/6777991372387391418'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2010/03/commercial-compliance-for.html' title='Commercial Compliance for Pharmaceutical and Medical Device Companies'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-3939911625959660506</id><published>2010-03-02T08:14:00.005-06:00</published><updated>2010-03-02T08:31:00.913-06:00</updated><title type='text'>Leveraging Digital Technology in Pharmaceutical Marketing: A New Agency Model</title><content type='html'>&lt;span class="Apple-style-span" style="font-family: 'Trebuchet MS', Arial, Helvetica, sans-serif; font-size: 11px; line-height: 15px;"&gt;&lt;b&gt;Date Posted:&lt;/b&gt; 01/19/2010  &lt;/span&gt;&lt;br /&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="font-family: 'Trebuchet MS', Arial, Helvetica, sans-serif; font-size: 11px; line-height: 15px;"&gt;&lt;b&gt;Size:&lt;/b&gt; 6.95MB  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="font-family: 'Trebuchet MS', Arial, Helvetica, sans-serif; font-size: 11px; line-height: 15px;"&gt;&lt;b&gt;Length:&lt;/b&gt; 00:15:11&lt;br /&gt;&lt;b&gt;Thought Leaders:&lt;/b&gt; Kurt Holstein, Co-Founder and President, Rosetta, and Steven Michaelson, Founder and CEO, Wishbone&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="font-family: 'Trebuchet MS', Arial, Helvetica, sans-serif; font-size: 11px; line-height: 15px;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="font-family: 'Trebuchet MS', Arial, Helvetica, sans-serif; font-size: 11px; line-height: 15px;"&gt;&lt;span class="Apple-style-span" style="color: #666666; font-style: italic;"&gt;Mr. Holstein and Mr. Michaelson discuss the benefits and challenges of the new agency model that has emerged with the growth of digitally enabled communications.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="font-family: 'Trebuchet MS', Arial, Helvetica, sans-serif; font-size: 11px; line-height: 15px;"&gt;&lt;span class="Apple-style-span" style="color: #666666; font-style: italic;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="font-family: 'Trebuchet MS', Arial, Helvetica, sans-serif; font-size: 11px; line-height: 15px;"&gt;&lt;a href="http://www.pharmavoice.com/xmlfiles/js/forcedownload.php?file=http://www.pharmavoice.com/webcasts/0210Wishbone/0210-Rosetta-Wishbone-edit1.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="color: #333333; font-family: 'times new roman';"&gt;&lt;span class="Apple-style-span" style="line-height: 20px;"&gt;&lt;span class="Apple-style-span" style="font-family: Georgia, serif; font-size: 13px;"&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-3939911625959660506?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/3939911625959660506/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=3939911625959660506' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/3939911625959660506'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/3939911625959660506'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2010/03/leveraging-digital-technology-in.html' title='Leveraging Digital Technology in Pharmaceutical Marketing: A New Agency Model'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-8104166084574503744</id><published>2009-12-01T18:08:00.002-06:00</published><updated>2009-12-01T18:12:35.003-06:00</updated><title type='text'>Performance-based Pricing in Patient Recruitment</title><content type='html'>&lt;span class="Apple-style-span" style="line-height: 15px; "&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'times new roman';"&gt;Date Posted:&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'times new roman';"&gt; 12/01/2009  &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="line-height: 15px; "&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'times new roman';"&gt;Size:&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'times new roman';"&gt; 14.4MB  &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="line-height: 15px; "&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'times new roman';"&gt;Length:&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'times new roman';"&gt; 00:14:04 &lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;b&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'times new roman';"&gt;Thought Leader:&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'times new roman';"&gt; Richard Malcolm Ph.D., CEO, Acurian&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="line-height: 15px; "&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'times new roman';"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="line-height: 15px; "&gt;&lt;span class="Apple-style-span" style="color: rgb(102, 102, 102); font-style: italic; "&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'times new roman';"&gt;Dr. Malcolm talks about risk sharing and performance-based pricing as a way for sponsors to get the best results for their patient recruiting budget.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span"  style="color:#666666;"&gt;&lt;span class="Apple-style-span" style="line-height: 15px; "&gt;&lt;i&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'times new roman';"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span"   style="font-family:'times new roman';color:#666666;"&gt;&lt;span class="Apple-style-span" style="font-size: small; line-height: 15px;"&gt;&lt;a href="http://www.pharmavoice.com/webcasts/1209Acurian/1209Acurian-Malcolm-edit1.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span"   style="font-family:'times new roman';color:#666666;"&gt;&lt;span class="Apple-style-span" style="font-size: small; line-height: 15px;"&gt;&lt;i&gt;&lt;br /&gt;&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span"  style="color:#666666;"&gt;&lt;span class="Apple-style-span" style="line-height: 15px; "&gt;&lt;i&gt;&lt;span class="Apple-style-span" style="color: rgb(51, 51, 51); font-style: normal; line-height: 20px; "&gt;&lt;span class="Apple-style-span" style="font-size: small;"&gt;&lt;span class="Apple-style-span"  style="font-family:'times new roman';"&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-8104166084574503744?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/8104166084574503744/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=8104166084574503744' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/8104166084574503744'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/8104166084574503744'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2009/12/performance-based-pricing-in-patient.html' title='Performance-based Pricing in Patient Recruitment'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-4275810199218402405</id><published>2009-10-30T15:24:00.002-05:00</published><updated>2009-10-30T15:28:42.984-05:00</updated><title type='text'>Podcast Overview</title><content type='html'>A 5-minute overview on Podcasts.&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;a href="http://www.zentation.com/viewer/index.php?passcode=vZyD7tfRw5"&gt;http://www.zentation.com/viewer/index.php?passcode=vZyD7tfRw5&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;Learn how PharmaVOICE produces, promotes, and distributes podcasts, and how to maximize exposure for your thought leaders to the pharmaceutical industry.&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-4275810199218402405?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/4275810199218402405/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=4275810199218402405' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/4275810199218402405'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/4275810199218402405'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2009/10/podcast-overview.html' title='Podcast Overview'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-158531886236152410</id><published>2009-10-01T00:05:00.003-05:00</published><updated>2009-10-13T11:57:18.814-05:00</updated><title type='text'>The Evolution of the E-Patient</title><content type='html'>&lt;div&gt;Date: 10/01/2009&lt;/div&gt;&lt;div&gt;Length: 00:20:13&lt;/div&gt;&lt;div&gt;Size: 9.25MB&lt;/div&gt;&lt;div&gt;Thought Leader: Bonnie Brescia, Founding Principal, BBK Worldwide&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;Ms. Brescia provides an overview of the e-patient, how this special patient population can be leveraged for clinical trial participation, and how social media are impacting recruitment and clinical research.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;a href="http://www.pharmavoice.com/webcasts/1009BBK/1009-BBK-Bonnie-Brescia-podcast.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-158531886236152410?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/158531886236152410/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=158531886236152410' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/158531886236152410'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/158531886236152410'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2009/10/evolution-of-e-patient.html' title='The Evolution of the E-Patient'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-7325778468591814719</id><published>2009-09-01T09:13:00.001-05:00</published><updated>2009-09-01T09:16:14.731-05:00</updated><title type='text'>Return On Investment in Patient Recruitment</title><content type='html'>&lt;div&gt;Date: 09/01/2009&lt;/div&gt;&lt;div&gt;Length: 00:22:47&lt;/div&gt;&lt;div&gt;Size: 10.4MB&lt;/div&gt;&lt;div&gt;Thought Leader: Richard Malcolm Ph.D., CEO, Acurian&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;Dr. Malcolm talks about planning and measuring return on investment in patient recruitment today, as well as what the future holds in this area.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="color: rgb(51, 51, 51); font-size: 11px; line-height: 20px; "&gt;&lt;span class="Apple-style-span" style="font-size: medium; "&gt;&lt;a href="http://www.pharmavoice.com/webcasts/0909Acurian/0909-Acurian-edit1.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-size: medium; "&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-7325778468591814719?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/7325778468591814719/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=7325778468591814719' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/7325778468591814719'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/7325778468591814719'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2009/09/return-on-investment-in-patient.html' title='Return On Investment in Patient Recruitment'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-4386900871910707818</id><published>2009-09-01T09:12:00.000-05:00</published><updated>2009-09-01T09:13:48.078-05:00</updated><title type='text'>Commercial Operations Outsourcing: A Leading-edge Response to the Financial Storm Affecting the Life-sciences Industry</title><content type='html'>&lt;div&gt;Date: 08/01/2009&lt;/div&gt;&lt;div&gt;Length: 00:17:26&lt;/div&gt;&lt;div&gt;Size: 12.31MB&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;Thought Leaders: Jassi Chadha, Head of Analytics Practice, Cognizant, Patrick Brundage, Practice Leader, Life Sciences Analytics, Cognizant, and Nagaraja Srivatsan, VP and Head of Life Sciences, North America, Cognizant&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;In this special PharmaVOICE 100 podcast, our thought leaders discuss the current state of the life-sciences industry, the changes it is experiencing now, and what the industry will look like in the next decade.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="color: rgb(51, 51, 51); font-size: 11px; line-height: 20px; "&gt;&lt;span class="Apple-style-span" style="font-size: medium; "&gt;&lt;a href="http://www.pharmavoice.com/webcasts/0709Cognizant/0709-Cognizant-edit2.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-size: medium; "&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-4386900871910707818?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/4386900871910707818/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=4386900871910707818' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/4386900871910707818'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/4386900871910707818'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2009/09/commercial-operations-outsourcing.html' title='Commercial Operations Outsourcing: A Leading-edge Response to the Financial Storm Affecting the Life-sciences Industry'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-1814805801053014058</id><published>2009-09-01T09:07:00.000-05:00</published><updated>2009-09-01T09:08:43.707-05:00</updated><title type='text'>The Digital Wave – Delivering Education and Services to Healthcare Providers</title><content type='html'>&lt;div&gt;Date: 08/01/2009&lt;/div&gt;&lt;div&gt;Length: 00:11:50&lt;/div&gt;&lt;div&gt;Size: 5.41MB&lt;/div&gt;&lt;div&gt;Thought Leader: Donato Tramuto, CEO and Vice Chairman, Physicians Interactive&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;In this special PharmaVOICE 100 podcast, Mr. Tramuto discusses digital technologies that educate and provide important services to healthcare providers to improve communication and help deliver better patient outcomes.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="color: rgb(51, 51, 51); font-size: 11px; line-height: 20px; "&gt;&lt;span class="Apple-style-span" style="font-size: medium; "&gt;&lt;a href="http://www.pharmavoice.com/webcasts/0709PI/0709-PI-edit1.mp3"&gt;Play Podcast&lt;/a&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-size: medium; "&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-1814805801053014058?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/1814805801053014058/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=1814805801053014058' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/1814805801053014058'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/1814805801053014058'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2009/09/digital-wave-delivering-education-and.html' title='The Digital Wave – Delivering Education and Services to Healthcare Providers'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-3922165448890187144</id><published>2009-09-01T09:03:00.004-05:00</published><updated>2009-09-01T09:12:31.462-05:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pharmavoice'/><category scheme='http://www.blogger.com/atom/ns#' term='podcast'/><category scheme='http://www.blogger.com/atom/ns#' term='HBA'/><title type='text'>The State of Women in Healthcare</title><content type='html'>&lt;span class="Apple-style-span"   style="  line-height: 16px; font-family:Arial;font-size:11px;"&gt;&lt;p style="text-align: auto;font-weight: normal; "&gt;&lt;span class="Apple-style-span"  style="color:#FF0000;"&gt;&lt;span class="Apple-style-span" style="font-weight: 800;"&gt;&lt;span class="Apple-style-span" style="color: rgb(0, 0, 0); font-weight: normal; "&gt;&lt;span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 1px; -webkit-border-vertical-spacing: 1px;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span class="Apple-style-span"  style="color:#FF0000;"&gt;&lt;span class="Apple-style-span" style="font-weight: 800;"&gt;&lt;span class="Apple-style-span" style="color: rgb(0, 0, 0); font-weight: normal; "&gt;&lt;span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 1px; -webkit-border-vertical-spacing: 1px;"&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;span class="Apple-style-span"  style="font-family:'times new roman';"&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;Date: 08/01/2009&lt;br /&gt;Length: 00:16:53&lt;br /&gt;Size: 7.75MB&lt;br /&gt;&lt;br /&gt;Thought Leader: Laurie P. Cooke, R.Ph., CEO, Healthcare Businesswomen's Association (HBA)&lt;br /&gt;&lt;br /&gt;In this special PharmaVOICE 100 podcast, Ms. Cooke outlines the current state of women in healthcare, discusses the importance of mentoring, and shares her views on volunteerism. This episode also provides an overview of the HBA and its upcoming Annual Leadership Conference — Limitless Leadership: Bridging Today, Tomorrow, and Beyond — in November 2009.&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="line-height: 20px; -webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px; color: rgb(51, 51, 51); "&gt;&lt;a href="http://www.pharmavoice.com/webcasts/0709HBA/0709-HBA-edit1.mp3"&gt;&lt;span class="Apple-style-span"  style="font-family:'times new roman';"&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;Play Podcast&lt;/span&gt;&lt;/span&gt;&lt;/a&gt;&lt;span class="Apple-style-span"  style="font-family:'times new roman';"&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;p&gt;&lt;/p&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-3922165448890187144?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/3922165448890187144/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=3922165448890187144' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/3922165448890187144'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/3922165448890187144'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2009/09/state-of-women-in-healthcare.html' title='The State of Women in Healthcare'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-6774801768237683932</id><published>2009-06-09T11:15:00.001-05:00</published><updated>2009-06-09T11:16:27.104-05:00</updated><title type='text'>Science is Greater than the Economy</title><content type='html'>Date: 05/29/2009&lt;br /&gt;Length: 00:11:46&lt;br /&gt;Size: 5.38MB&lt;br /&gt;&lt;br /&gt;Thought Leaders: Lawrence Reiter, Ph.D., Director of Global Affairs, Criterium Inc.&lt;br /&gt;&lt;br /&gt;Dr. Reiter discusses why it’s important to maintain R&amp;amp;D spending during fiscally challenging times, the pros and cons of a global R&amp;amp;D plan, how to do more with less, what technology brings to the table, and other critical factors to improve the development process.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/webcasts/0609Criterium/0609-Criterium-edit1.mp3"&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-6774801768237683932?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/6774801768237683932/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=6774801768237683932' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/6774801768237683932'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/6774801768237683932'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2009/06/science-is-greater-than-economy.html' title='Science is Greater than the Economy'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-500039210837220685</id><published>2009-06-09T11:12:00.002-05:00</published><updated>2009-06-09T11:15:08.342-05:00</updated><title type='text'>Charting a New Course by Catalyzing Transformation</title><content type='html'>Date: 05/28/2009&lt;br /&gt;Length: 00:14:56&lt;br /&gt;Size: 6.84MB&lt;br /&gt;&lt;br /&gt;Thought Leaders: Adrian McKemey, Ph.D. Managing Director, Quintiles Consulting&lt;br /&gt;Michael Arlotto, Ph.D., Senior Vice President, Quintiles Corporate Development.&lt;br /&gt;&lt;br /&gt;In episode three, of a three-part series, “Surviving to Thriving in Stormy Weather,” our thought leaders discuss declining R &amp;amp; D productivity combined with increasing development costs. They offer insights and solutions to maximizing efficiencies and effecting change within R &amp;amp; D organizations in the biopharma industry.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/webcasts/0609Quintiles/0609-Quintiles3-edit1.mp3"&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/rebalance"&gt;Download Related Whitepaper&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-500039210837220685?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/500039210837220685/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=500039210837220685' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/500039210837220685'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/500039210837220685'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2009/06/charting-new-course-by-catalyzing.html' title='Charting a New Course by Catalyzing Transformation'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-5581264631972621523</id><published>2009-06-09T11:09:00.001-05:00</published><updated>2009-06-09T11:12:11.810-05:00</updated><title type='text'>How to Connect Patients and Physicians Around Your Brand</title><content type='html'>Date: 05/27/2009&lt;br /&gt;Length: 00:17:57&lt;br /&gt;Size: 8.22MB&lt;br /&gt;&lt;br /&gt;Thought Leaders: Michael Ball, Ph.D., VP of Marketing, InfoMedics&lt;br /&gt;Paul LeVine, VP of Analytical Services, InfoMedics&lt;br /&gt;&lt;br /&gt;In this episode, Dr. Ball and Mr. LeVine discuss the importance of patient feedback – how to obtain it and how it can be used to better connect brands with patients and physicians in a practice setting.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/webcasts/0609InfoMedics/0609-InfoMedics-edit1.mp3"&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/satisfaction"&gt;Download Related Whitepaper&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-5581264631972621523?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/5581264631972621523/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=5581264631972621523' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/5581264631972621523'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/5581264631972621523'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2009/06/how-to-connect-patients-and-physicians.html' title='How to Connect Patients and Physicians Around Your Brand'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-6373449664119409587</id><published>2009-06-09T11:07:00.001-05:00</published><updated>2009-06-09T11:08:52.120-05:00</updated><title type='text'>Connecting through Electronic Health Records</title><content type='html'>Date: 05/26/2009&lt;br /&gt;Length: 00:14:41&lt;br /&gt;Size: 6.72MB&lt;br /&gt;&lt;br /&gt;Thought Leaders: Landen Bain, Liaison to Healthcare, CDISC&lt;br /&gt;Dave Iberson-Hurst, VP of Technical Strategy, CDISC&lt;br /&gt;&lt;br /&gt;In this episode, Mr. Bain and Mr. Iberson-Hurst discuss CDISC’s efforts in instituting standards for Electronic Health Records and RFD - Retrieve Form for Data Capture. They also cover where the organization’s efforts will be applied in the future.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/webcasts/0609CDISC/0609-CDISC-edit1.mp3"&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-6373449664119409587?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/6373449664119409587/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=6373449664119409587' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/6373449664119409587'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/6373449664119409587'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2009/06/connecting-through-electronic-health.html' title='Connecting through Electronic Health Records'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-708807554278821406</id><published>2009-06-09T11:01:00.002-05:00</published><updated>2009-06-09T11:06:55.179-05:00</updated><title type='text'>Making Headway in Shifting Winds by Maximizing Value</title><content type='html'>Date: 5/01/2009&lt;br /&gt;Length: 00:19:08&lt;br /&gt;Size: 8.76MB&lt;br /&gt;&lt;br /&gt;Thought Leaders: James Featherstone, Ph.D., VP of Product Development and Commercialization for the EU, Quintiles Consulting, Bruce E. Johnson, Ph.D., Senior Research Director, Eidetics, a division of Quintiles Consulting, and Heidi Hunter, Global VP, Business Development, Quintiles&lt;br /&gt;&lt;br /&gt;In episode two, of a three-part series, "Surviving to Thriving in Stormy Weather," our thought leaders discuss new commercialization processes as healthcare moves towards personalized medicine. They also cover how to assess market potential for personalized therapies, post-launch sales strategies for niche drugs, and finally, meeting the needs of global and regional markets for these types of therapies.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/resources/podcast.siml?title=Making+Headway+in+Shifting+Winds+by+Maximizing+Value&amp;amp;date=5%2F01%2F2009&amp;amp;length=00%3A19%3A08&amp;amp;size=8.76MB&amp;amp;comment=Thought+Leaders%3A++James+Featherstone,+Ph.D.,+VP"&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-708807554278821406?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/708807554278821406/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=708807554278821406' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/708807554278821406'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/708807554278821406'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2009/06/making-headway-in-shifting-winds-by.html' title='Making Headway in Shifting Winds by Maximizing Value'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-3327558034148540128</id><published>2009-04-30T09:38:00.002-05:00</published><updated>2009-04-30T09:43:40.532-05:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pharmavoice'/><category scheme='http://www.blogger.com/atom/ns#' term='limbach'/><category scheme='http://www.blogger.com/atom/ns#' term='podcast'/><category scheme='http://www.blogger.com/atom/ns#' term='i3'/><title type='text'>Better Standards and Metrics for CROs and Sponsors</title><content type='html'>Date:4/08/2009&lt;br /&gt;Length: 00:14:29&lt;br /&gt;Size: 6.63MB&lt;br /&gt;Thought Leaders:&lt;br /&gt;Gregg Dearhammer, President, i3 Statprobe&lt;br /&gt;Karen Goss, Global Director, Pharmacovigilance, i3 Drug Safety&lt;br /&gt;&lt;br /&gt;In this episode, Mr. Dearhammer and Ms. Goss discuss the need for metrics and standards for clinical trials management and the impact of the Metrics Champion Consortium (MCC) on CROs and sponsors.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/webcasts/dearhammer/0409-i3-edit1.mp3" mp3="'%2Fwebcasts%2Fdearhammer%2F0409-i3-edit1.mp3&amp;amp;transcript="&gt;Play podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-3327558034148540128?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/3327558034148540128/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=3327558034148540128' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/3327558034148540128'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/3327558034148540128'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2009/04/better-standards-and-metrics-for-cros.html' title='Better Standards and Metrics for CROs and Sponsors'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-3667209946979303922</id><published>2009-04-02T10:19:00.000-05:00</published><updated>2009-04-02T10:20:31.776-05:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='kirk'/><category scheme='http://www.blogger.com/atom/ns#' term='pharmavoice'/><category scheme='http://www.blogger.com/atom/ns#' term='quintiles'/><category scheme='http://www.blogger.com/atom/ns#' term='limbach'/><category scheme='http://www.blogger.com/atom/ns#' term='hagen'/><category scheme='http://www.blogger.com/atom/ns#' term='podcast'/><title type='text'>Setting Sail for Success by Optimizing Productivity</title><content type='html'>Date:4/01/2009&lt;br /&gt;Length: 00:14:31&lt;br /&gt;Size: 6.64MB&lt;br /&gt;&lt;br /&gt;Thought Leaders: Michael Hagan, Principal Consultant, Quintiles Consulting and James C. Kirk, VP and Practice Leader, Eidetics, Quintiles Consulting&lt;br /&gt;&lt;br /&gt;In episode one, of a three-part series, “Surviving to Thriving in Stormy Weather,” Mr. Hagan and Mr. Kirk discuss market pressures and how economic turmoil in the biopharma industry can be overcome by using process optimization.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/webcasts/hagan/0409-quintiles-podcast1-edit1.mp3"&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-3667209946979303922?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/3667209946979303922/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=3667209946979303922' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/3667209946979303922'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/3667209946979303922'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2009/04/setting-sail-for-success-by-optimizing.html' title='Setting Sail for Success by Optimizing Productivity'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-8664701584080766301</id><published>2009-03-12T08:50:00.001-05:00</published><updated>2009-03-12T08:51:28.401-05:00</updated><title type='text'>Overcoming Global Marketing and Regulatory Challenges</title><content type='html'>Date:3/02/2009&lt;br /&gt;Length: 00:012:37&lt;br /&gt;Size: 5.77MB&lt;br /&gt;&lt;br /&gt;Thought Leaders: John Doyle Dr.P.H., Managing Director and Practice Leader, Market Access, Quintiles Consulting, and Geoff Garabedian, Managing Director and Practice Leader, Regulatory, Quintiles Consulting&lt;br /&gt;&lt;br /&gt;In this episode, Dr. Doyle outlines cost-based evaluation and market-access strategies based on comparative effectiveness and safety research. Then Mr. Garabedian talks about the impact of regulatory globalization, and finally, there is a discussion covering the latest pharmaceutical initiatives from the European Commission, and how these will impact the global healthcare industry.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/webcasts/doyle/0209-Quintiles-edit1.mp3"&gt;Play P0dcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-8664701584080766301?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/8664701584080766301/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=8664701584080766301' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/8664701584080766301'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/8664701584080766301'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2009/03/overcoming-global-marketing-and.html' title='Overcoming Global Marketing and Regulatory Challenges'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-6265326023239606104</id><published>2009-03-12T08:48:00.001-05:00</published><updated>2009-03-12T08:50:01.892-05:00</updated><title type='text'>Global Clinical Trials Outsourcing: New Tips and Trends</title><content type='html'>Date:3/02/2009&lt;br /&gt;Length: 00:012:25&lt;br /&gt;Size: 5.68MB&lt;br /&gt;&lt;br /&gt;Thought Leader: Patrick Durbin, VP, Fisher Clinical Services (a division of Thermo Fisher Scientific)&lt;br /&gt;&lt;br /&gt;In this episode, Mr. Durbin offers some best practices for developing a strategic partnership with outsourcing providers, discusses some of the biggest challenges and missteps in global clinical trials outsourcing, covers emerging opportunities at the global level, and lists some of the most important emerging trends in this arena.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/webcasts/durbin/0209-Fisher-edit1.mp3"&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-6265326023239606104?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/6265326023239606104/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=6265326023239606104' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/6265326023239606104'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/6265326023239606104'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2009/03/global-clinical-trials-outsourcing-new.html' title='Global Clinical Trials Outsourcing: New Tips and Trends'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-5252969478652585962</id><published>2009-03-12T08:47:00.001-05:00</published><updated>2009-03-12T08:48:48.488-05:00</updated><title type='text'>Driving Sales Force Effectiveness in Turbulent Times</title><content type='html'>Date:2/23/2009&lt;br /&gt;Length: 00:011:51&lt;br /&gt;Size: 5.42MB&lt;br /&gt;&lt;br /&gt;Thought Leader: Brett Knowles, Founder, Performance Measurement and Management&lt;br /&gt;&lt;br /&gt;In this episode, Mr. Knowles discusses an actionable approach to boosting sales force performance, and how it has delivered results for Pharmaceutical companies in today's challenging environment.&lt;br /&gt;&lt;br /&gt;Free Whitepaper Paper for download: Five Steps to Pharma Sales Force Effectiveness &lt;a href="http://www.cognos.com/saleseffectiveness"&gt;Click Here&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/webcasts/knowles/1108-Cognos1-edit2-mixed.mp3"&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-5252969478652585962?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/5252969478652585962/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=5252969478652585962' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/5252969478652585962'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/5252969478652585962'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2009/03/driving-sales-force-effectiveness-in.html' title='Driving Sales Force Effectiveness in Turbulent Times'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-423991902883523102</id><published>2009-03-12T08:44:00.001-05:00</published><updated>2009-03-12T08:46:38.264-05:00</updated><title type='text'>Pharmaceutical Forecasting Insights: The Process, Hurdles, and Important Trends</title><content type='html'>Date:1/30/2009&lt;br /&gt;Length: 00:013:28&lt;br /&gt;Size: 6.16MB&lt;br /&gt;&lt;br /&gt;Thought Leader: Todd Johnson, Director of Forecasting, MattsonJack&lt;br /&gt;&lt;br /&gt;In this episode, we discuss the importance and benefits of having an effective forecasting process, hurdles to implementation, available tools, and trends in the forecasting arena, particularly oncology forecasting. MattsonJack is holding a live workshop on forecasting in Scottsdale, AZ March 19-20. The workshop offers best practices, real-world tips and expert advice. To learn more about this important event &lt;a href="http://mattsonjack.com/seminar_offerings.asp"&gt;Click Here.&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/webcasts/johnson/0109-MattsonJack-edit1-mixed.mp3"&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-423991902883523102?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/423991902883523102/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=423991902883523102' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/423991902883523102'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/423991902883523102'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2009/03/pharmaceutical-forecasting-insights.html' title='Pharmaceutical Forecasting Insights: The Process, Hurdles, and Important Trends'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-2485456414046273540</id><published>2009-03-12T08:43:00.000-05:00</published><updated>2009-03-12T08:44:26.811-05:00</updated><title type='text'>John Crowley’s Personal Crusade</title><content type='html'>Date:12/30/2008&lt;br /&gt;Length: 00:07:18&lt;br /&gt;Size: 3.34MB&lt;br /&gt;&lt;br /&gt;Thought Leader: John Crowley, President and CEO, Amicus Therapeutics&lt;br /&gt;&lt;br /&gt;In this episode, Mr. Crowley shares his personal journey to find viable treatements for Pompe disease, a condition which two of his children are afflicted. His amazing story is also showcased in the January issue of PharmaVOICE.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/webcasts/crowley/1208-Amicus-Crowley-edit1-mixed.mp3"&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-2485456414046273540?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/2485456414046273540/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=2485456414046273540' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/2485456414046273540'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/2485456414046273540'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2009/03/john-crowleys-personal-crusade.html' title='John Crowley’s Personal Crusade'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-8555449295505285682</id><published>2009-03-12T08:40:00.001-05:00</published><updated>2009-03-12T08:42:29.629-05:00</updated><title type='text'>Understanding the New PhRMA Code for Medically Relevant Items</title><content type='html'>Date:12/30/2008&lt;br /&gt;Length: 00:13:00&lt;br /&gt;Size: 5.95MB&lt;br /&gt;&lt;br /&gt;Thought Leader: David Ganz, Managing Director, Total Health Rewards&lt;br /&gt;&lt;br /&gt;In this episode, Mr. Ganz discusses the new PhRMA code as it relates to medically relevant items (MRIs) and how companies can stay compliant with this new guideline.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/webcasts/ganz/1208TotalHealthRewards-edit1-mixed.mp3"&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-8555449295505285682?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/8555449295505285682/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=8555449295505285682' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/8555449295505285682'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/8555449295505285682'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2009/03/understanding-new-phrma-code-for.html' title='Understanding the New PhRMA Code for Medically Relevant Items'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-3777770597606288195</id><published>2008-12-15T10:04:00.003-06:00</published><updated>2009-03-12T08:39:58.640-05:00</updated><title type='text'>Critical Care Opportunities in a Global Arena</title><content type='html'>Date:12/15/2008&lt;br /&gt;Length: 00:12:05&lt;br /&gt;Size: 5.50MB&lt;br /&gt;Thought Leader: Clive Meanwell, M.D., PhD., Chairman and CEO, The Medicines Company&lt;br /&gt;&lt;br /&gt;In this episode we talk about moving from a US focused to a globally focused company. We discuss several factors impacting the global pharmaceutical and healthcare market, and how outcomes research will be used in the future in the US and ex-US&lt;br /&gt;&lt;br /&gt;&lt;a onclick="return winControl(href, '450', '400', 'podcasts')" href="http://www.pharmavoice.com/webcasts/ribotsky/1108-Core-Create-edit1-mixed.mp3" mp3="%2Fwebcasts%2Fribotsky%2F1108-Core-Create-edit1-mixed.mp3&amp;amp;transcript=" size="5.46MB&amp;amp;comment=" date="'11%2F19%2F2008&amp;amp;length="&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157 .&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-3777770597606288195?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/3777770597606288195/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=3777770597606288195' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/3777770597606288195'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/3777770597606288195'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2008/12/critical-care-opportunities-in-global.html' title='Critical Care Opportunities in a Global Arena'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-8558392284105462465</id><published>2008-11-20T14:14:00.005-06:00</published><updated>2008-12-05T10:10:54.729-06:00</updated><title type='text'>Demystifying Social Media — It's Not About Controlling the Message</title><content type='html'>Date:11/19/2008&lt;br /&gt;Length: 00:11:56&lt;br /&gt;Size: 5.46MB&lt;br /&gt;Thought Leader: Ken Ribotsky, President and CEO, Core-Create&lt;br /&gt;&lt;br /&gt;In this episode, Mr. Ribotsky discusses the relatively new web phenomenon called Social Media – what it is and how it can be used for improving brand messaging and communications.&lt;br /&gt;&lt;br /&gt;&lt;a onclick="return winControl(href, '450', '400', 'podcasts')" href="http://www.pharmavoice.com/webcasts/ribotsky/1108-Core-Create-edit1-mixed.mp3" date="'11%2F19%2F2008&amp;amp;length=" size="5.46MB&amp;amp;comment=" mp3="%2Fwebcasts%2Fribotsky%2F1108-Core-Create-edit1-mixed.mp3&amp;amp;transcript="&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157 .&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-8558392284105462465?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/8558392284105462465/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=8558392284105462465' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/8558392284105462465'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/8558392284105462465'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2008/11/demystifying-social-media-its-not-about.html' title='Demystifying Social Media — It&apos;s Not About Controlling the Message'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-1924195330923914266</id><published>2008-11-20T14:14:00.004-06:00</published><updated>2008-12-05T10:09:31.258-06:00</updated><title type='text'>Achieve Optimal Messaging for Your Inline Brand</title><content type='html'>Date:11/19/2008&lt;br /&gt;Length: 00:16:21&lt;br /&gt;Size: 7.48MB&lt;br /&gt;Thought Leader: Ian McKinnon Ph.D., Senior Vice President, TNS Healthcare&lt;br /&gt;&lt;br /&gt;In this episode, Dr. McKinnon discusses how brand teams can optimize their messages, evaluate their messengers (sales reps), and minimize the damage from competing messages in their market space.&lt;br /&gt;&lt;br /&gt;&lt;a onclick="return winControl(href, '450', '400', 'podcasts')" href="http://www.pharmavoice.com/webcasts/mckinnon/1108-TNS-edit1-mixed.mp3"&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmalinx.com/TNS/SalesCalls/index.html"&gt;Download Related Presentation&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157 .&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-1924195330923914266?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/1924195330923914266/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=1924195330923914266' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/1924195330923914266'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/1924195330923914266'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2008/11/achieve-optimal-messaging-for-your.html' title='Achieve Optimal Messaging for Your Inline Brand'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-7141833857771133081</id><published>2008-11-20T14:13:00.003-06:00</published><updated>2008-12-05T10:07:26.938-06:00</updated><title type='text'>The Benefits and Challenges of Creating Personalized Brand Dialogue Between Physicians and Patients</title><content type='html'>Date:11/19/2008&lt;br /&gt;Length: 00:17:28&lt;br /&gt;Size: 8.00MB&lt;br /&gt;Thought Leaders: Paul LeVine, VP Analytical Services, InfoMedics and Dr. Stanley Wulf, Chief Medical Officer, InfoMedics&lt;br /&gt;&lt;br /&gt;In this episode, Mr. LeVine and Dr. Wulf discuss ways to improve the dialog between physicians and patients using personalized data and communication tools in an effort to increase patient retention and health outcomes.&lt;br /&gt;&lt;br /&gt;&lt;a onclick="return winControl(href, '450', '400', 'podcasts')" href="http://www.pharmavoice.com/webcasts/levine/1108-InfoMedics-edit2-mixed.mp3"&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157 .&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-7141833857771133081?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/7141833857771133081/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=7141833857771133081' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/7141833857771133081'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/7141833857771133081'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2008/11/benefits-and-challenges-of-creating.html' title='The Benefits and Challenges of Creating Personalized Brand Dialogue Between Physicians and Patients'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-5792518597942425689</id><published>2008-11-20T14:12:00.002-06:00</published><updated>2008-12-05T10:01:15.162-06:00</updated><title type='text'>Procuring and Managing Clinical Staffing Resources</title><content type='html'>Date:11/19/2008&lt;br /&gt;Length: 00:15:03&lt;br /&gt;Size: 6.89MB&lt;br /&gt;Thought Leader: Stephen Cottrell, Executive V.P. of Operations and Business Development, inVentiv Clinical Solutions&lt;br /&gt;&lt;br /&gt;In this episode, Mr. Cottrell outlines many of the challenges in procuring and managing clinical staffing resources, and offers advice on how to overcome them.&lt;br /&gt;&lt;br /&gt;&lt;a onclick="return winControl(href, '450', '400', 'podcasts')" href="http://www.pharmavoice.com/webcasts/cottrell/1008-inVentivSRG-edit4-mixed.mp3"&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157 .&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-5792518597942425689?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/5792518597942425689/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=5792518597942425689' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/5792518597942425689'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/5792518597942425689'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2008/11/procuring-and-managing-clinical.html' title='Procuring and Managing Clinical Staffing Resources'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-1195032717486331968</id><published>2008-11-20T14:11:00.001-06:00</published><updated>2008-12-05T09:56:19.497-06:00</updated><title type='text'>Ensuring Launch Success: Payer and Prescriber Considerations in</title><content type='html'>Thought Leader: Sarah Rickwood, Senior Principal, IMS&lt;br /&gt;&lt;br /&gt;&lt;a onclick="return winControl(href, '450', '400', 'podcasts')" href="http://www.pharmavoice.com/webcasts/rickwood/sarah-rickwood-vpodcast-mixed.mp3" date="'11%2F14%2F2008&amp;amp;length=" size="4.80MB&amp;amp;comment=" mp3="%2Fwebcasts%2Frickwood%2Fsarah-rickwood-vpodcast-mixed.mp3&amp;amp;transcript="&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/content/industryevents/videocasts/IMS_launchsuccess.html"&gt;Link to Related Videocast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157 .&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-1195032717486331968?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/1195032717486331968/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=1195032717486331968' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/1195032717486331968'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/1195032717486331968'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2008/11/ensuring-launch-success-payer-and.html' title='Ensuring Launch Success: Payer and Prescriber Considerations in'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-2122224670277739198</id><published>2008-11-20T14:09:00.007-06:00</published><updated>2008-12-05T09:58:58.081-06:00</updated><title type='text'>Fresh Approaches to Launch Success</title><content type='html'>Thought Leader: Robert Harold, Senior Principal, IMS&lt;br /&gt;&lt;br /&gt;&lt;a onclick="return winControl(href, '450', '400', 'podcasts')" href="http://www.pharmavoice.com/webcasts/harold/rob-launch-vpodcast-mixed.mp3"&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/content/industryevents/videocasts/IMS_freshapproach.html"&gt;Link to Related Videocast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157 .&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-2122224670277739198?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/2122224670277739198/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=2122224670277739198' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/2122224670277739198'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/2122224670277739198'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2008/11/fresh-approaches-to-launch-success.html' title='Fresh Approaches to Launch Success'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-8212750377210769198</id><published>2008-11-20T14:09:00.004-06:00</published><updated>2008-12-05T08:43:30.142-06:00</updated><title type='text'>Winning in the Dynamic Market: Novel Approaches</title><content type='html'>Thought Leader: Lisa Morris, Global APLD Services, IMS&lt;br /&gt;&lt;br /&gt;&lt;a onclick="return winControl(href, '450', '400', 'podcasts')" href="http://www.pharmavoice.com/webcasts/morris/lisa-winning-vpodcast-mixed.mp3"&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/content/industryevents/videocasts/IMS_winningdynamic.html"&gt;Link to Related Videocast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157 .&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-8212750377210769198?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/8212750377210769198/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=8212750377210769198' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/8212750377210769198'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/8212750377210769198'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2008/11/winning-in-dynamic-market-novel.html' title='Winning in the Dynamic Market: Novel Approaches'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-2382759934194189819</id><published>2008-11-20T14:08:00.002-06:00</published><updated>2008-12-05T09:49:48.737-06:00</updated><title type='text'>The Dynamic Market: Why It's the Most Important Area of Focus for Your Brand</title><content type='html'>Thought Leader: Robert Harold, Senior Principal, IMS&lt;br /&gt;&lt;br /&gt;&lt;a onclick="return winControl(href, '450', '400', 'podcasts')" href="http://www.pharmavoice.com/webcasts/harold/rob-dynamic-market-vpodcast-mixed.mp3" date="'11%2F14%2F2008&amp;amp;length=" size="2.90MB&amp;amp;comment=" mp3="%2Fwebcasts%2Fharold%2Frob-dynamic-market-vpodcast-mixed.mp3&amp;amp;transcript="&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/content/industryevents/videocasts/IMS_dynamicmarket.html"&gt;Link to Related Videocast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157 .&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-2382759934194189819?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/2382759934194189819/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=2382759934194189819' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/2382759934194189819'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/2382759934194189819'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2008/11/dynamic-market-why-its-most-important.html' title='The Dynamic Market: Why It&apos;s the Most Important Area of Focus for Your Brand'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-3588963623758970848</id><published>2008-11-20T14:07:00.002-06:00</published><updated>2008-12-05T08:40:50.096-06:00</updated><title type='text'>Changing the Game: New Opportunities in the Dynamic Market</title><content type='html'>Thought Leader: Lisa Morris, Global APLD Services, IMS&lt;br /&gt;&lt;br /&gt;&lt;a onclick="return winControl(href, '450', '400', 'podcasts')" href="http://www.pharmavoice.com/webcasts/morris/lisa-newopportunities-vpodcast-mixed.mp3"&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/content/industryevents/videocasts/IMS_changinggame.html"&gt;Link to Related Videocast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157 .&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-3588963623758970848?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/3588963623758970848/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=3588963623758970848' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/3588963623758970848'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/3588963623758970848'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2008/11/changing-game-new-opportunities-in.html' title='Changing the Game: New Opportunities in the Dynamic Market'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-1183056400753040081</id><published>2008-11-20T14:05:00.002-06:00</published><updated>2008-12-05T08:36:08.776-06:00</updated><title type='text'>A Dual-Degree MSPharm/MBA Online Program Update</title><content type='html'>Date:10/17/2008&lt;br /&gt;Length: 00:07:52&lt;br /&gt;Size: 3.60MB&lt;br /&gt;Program Representative: David B. Brushwood, R.Ph., J.D., Professor of Pharmaceutical Outcomes and Policy, University of Florida&lt;br /&gt;&lt;br /&gt;In this episode, Professor Brushwood provides an update on a new online dual-degree program: a Master of Science in Pharmacy degree from the University of Florida and a Master of Business Administration from Stetson University. He discusses the benefits of the dynamic dual-degree, the program structure, the advantages of an online program, and admission requirements. Current registration period ends after November 1, 2008.&lt;br /&gt;&lt;br /&gt;&lt;a onclick="return winControl(href, '450', '400', 'podcasts')" href="http://www.pharmavoice.com/webcasts/uflorida/1008-UFlorida-edit1-mixed.mp3"&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157 .&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-1183056400753040081?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/1183056400753040081/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=1183056400753040081' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/1183056400753040081'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/1183056400753040081'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2008/11/dual-degree-mspharmmba-online-program.html' title='A Dual-Degree MSPharm/MBA Online Program Update'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-721104835774821403</id><published>2008-09-29T13:51:00.002-05:00</published><updated>2008-09-29T14:54:57.478-05:00</updated><title type='text'>eClinical Moves into the Mainstream</title><content type='html'>Date:9/11/2008&lt;br /&gt;Length: 00:13:28&lt;br /&gt;Size: 6.17MB&lt;br /&gt;&lt;br /&gt;Thought Leader: Stacey Arrambide, VP, Statistics and Data Management, inVentiv Clinical Solutions&lt;br /&gt;&lt;br /&gt;In this episode, Stacey Arrambide shares her insights about the eClinical arena -- how it has evolved and what the benefits are, particularly regarding cost savings.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/webcasts/arrambide/inventiv-edit1-mixed.mp3"&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157 .&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-721104835774821403?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/721104835774821403/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=721104835774821403' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/721104835774821403'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/721104835774821403'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2008/09/eclinical-moves-into-mainstream.html' title='eClinical Moves into the Mainstream'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-8609222550248850685</id><published>2008-09-29T13:48:00.003-05:00</published><updated>2008-09-29T14:56:21.628-05:00</updated><title type='text'>Fighting Back: Technology Solutions to the Counterfeit Drug Problem</title><content type='html'>Date: 9/22/2008&lt;br /&gt;Length: 00:15:56&lt;br /&gt;Size: 7.29MB&lt;br /&gt;Thought Leader: MaryAnn Hegedus, Business Development Manager, Colorcon&lt;br /&gt;&lt;br /&gt;In this episode, Ms. Hegedus discusses the implications of the counterfeit drug market, and offers insights on how companies can use authentication technologies to protect their revenue, enable security throughout the entire supply chain at the dosage level, and improve consumer confidence.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/webcasts/hegedus/0908-Colorcon-edit3-mixed.mp3"&gt;Play Podcast&lt;br /&gt;&lt;/a&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157 .&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-8609222550248850685?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/8609222550248850685/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=8609222550248850685' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/8609222550248850685'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/8609222550248850685'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2008/09/fighting-back-technology-solutions-to.html' title='Fighting Back: Technology Solutions to the Counterfeit Drug Problem'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-6470784629818695819</id><published>2008-09-29T13:41:00.005-05:00</published><updated>2008-09-29T14:52:14.275-05:00</updated><title type='text'>The Pharma-Physician-Patient Connection: Working Together to Improve Treatment Outcomes</title><content type='html'>Date: 9/8/2008&lt;br /&gt;Length: 00:14.49&lt;br /&gt;Size: 6.78MB&lt;br /&gt;&lt;br /&gt;Thought Leaders:&lt;br /&gt;Dr. Stanley Wulf, Chief Medical Officer, InfoMedics&lt;br /&gt;Ray Bullman, Executive VP of NCPIE (National Council on Patient Information and Education)&lt;br /&gt;&lt;br /&gt;In this episode, our thought leaders share insights on improving treatment outcomes through patient adherence programs, including best practices and a look into the future of adherence programs.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/webcasts/wulf/0908-infoMedics-edit2-mixed.mp3"&gt;Play Podcast&lt;br /&gt;&lt;/a&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-6470784629818695819?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/6470784629818695819/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=6470784629818695819' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/6470784629818695819'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/6470784629818695819'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2008/09/pharma-physician-patient-connection.html' title='The Pharma-Physician-Patient Connection: Working Together to Improve Treatment Outcomes'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-4832039182748703959</id><published>2008-09-11T09:02:00.002-05:00</published><updated>2008-09-11T09:35:12.107-05:00</updated><title type='text'>Molecular Design and the Critical Path Problem</title><content type='html'>Date:9/08/2008&lt;br /&gt;Length: 00:16:35&lt;br /&gt;Size: 7.59MB&lt;br /&gt;&lt;br /&gt;Thought Leader: Stephen Byrn, Ph. D., Charles B. Jordan Professor of Medicinal Chemistry and Head of the Department of Industrial and Physical Pharmacy, Purdue University; and Head of the Aptuit Scientific Advisory Board&lt;br /&gt;&lt;br /&gt;In this episode, Dr. Byrn speaks about the critical path problem in drug development and how a designed molecular delivery system can improve the drug development process.&lt;br /&gt;&lt;br /&gt;&lt;a onclick="return winControl(href, '450', '400', 'podcasts')" href="http://www.pharmavoice.com/webcasts/byrn/0808Aptuit-edit1-mixed.mp3"&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.aptuit.com/moleculardesign/"&gt;Download free related whitepaper&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-4832039182748703959?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/4832039182748703959/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=4832039182748703959' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/4832039182748703959'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/4832039182748703959'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2008/09/molecular-design-and-critical-path.html' title='Molecular Design and the Critical Path Problem'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-4260896070256192792</id><published>2008-07-31T10:20:00.001-05:00</published><updated>2008-09-11T09:37:29.706-05:00</updated><title type='text'>E-Clinical: Driving Efficiencies and Reducing Costs for Drug Development</title><content type='html'>Date:7/30/2008&lt;br /&gt;Length: 00:16:44&lt;br /&gt;Size: 7.66MB&lt;br /&gt;Thought Leader: Chris Porter, Cofounder and Chief Operating Officer, Clinipace&lt;br /&gt;&lt;br /&gt;In this episode, Taren Grom, Editor, PharmaVOICE, speaks with 2008 PharmaVOICE 100 honoree Chris Porter about the need for a better clinical model, one driven by affordable technology and software solutions, as well as best practices to improve clinical research processes.&lt;br /&gt;&lt;br /&gt;&lt;a onclick="return winControl(href, '450', '400', 'podcasts')" href="http://www.pharmavoice.com/webcasts/porter/0708-Clinipace-edit2-mixed.mp3"&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-4260896070256192792?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/4260896070256192792/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=4260896070256192792' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/4260896070256192792'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/4260896070256192792'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2008/07/e-clinical-driving-efficiencies-and.html' title='E-Clinical: Driving Efficiencies and Reducing Costs for Drug Development'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-1087743935931054430</id><published>2008-07-31T10:18:00.002-05:00</published><updated>2008-09-11T09:38:20.381-05:00</updated><title type='text'>Insights on Developing a Career Path in the New Era of the Life Sciences</title><content type='html'>Date:7/30/2008&lt;br /&gt;Length: 00:15:08&lt;br /&gt;Size: 6.93MB&lt;br /&gt;Thought Leader: Howard Weisman, CoFounder, CEO, and Chairman, EKR Therapeutics Inc.&lt;br /&gt;&lt;br /&gt;In this episode, Taren Grom, Editor, PharmaVOICE, speaks with Mr. Weisman, a 2008 PharmaVOICE 100 honoree, about how to maximize career opportunities in the pharmaceutical industry and how the career paths are changing.&lt;br /&gt;&lt;br /&gt;&lt;a onclick="return winControl(href, '450', '400', 'podcasts')" href="http://www.pharmavoice.com/webcasts/weisman/0708-EKR-edit2-mixed.mp3"&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-1087743935931054430?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/1087743935931054430/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=1087743935931054430' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/1087743935931054430'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/1087743935931054430'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2008/07/insights-on-developing-career-path-in.html' title='Insights on Developing a Career Path in the New Era of the Life Sciences'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-5778169315788071002</id><published>2008-07-18T16:40:00.006-05:00</published><updated>2008-09-11T09:41:05.398-05:00</updated><title type='text'>Mobile Devices: Connecting Physicians and Pharma</title><content type='html'>Date:7/15/2008&lt;br /&gt;Length: 00:10:38&lt;br /&gt;Size: 4.87MB&lt;br /&gt;Thought Leader: Sandeep Shah, President and Founder, Skyscape&lt;br /&gt;&lt;br /&gt;In this episode, Taren Grom, Editor, PharmaVOICE, speaks with Mr. Shah about the importance of wireless mobile devices to physicians and how pharmaceutical companies can leverage this platform for physician communications.Free Report: Effect of PDA-Based Information on Treatment Decisions&lt;br /&gt;&lt;br /&gt;&lt;a onclick="return winControl(href, '450', '400', 'podcasts')" href="http://www.pharmavoice.com/webcasts/shah/0708-Skyscape-edit2-mixed.mp3"&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://pharma.skyscape.com/downloads"&gt;Download Related Free Report&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-5778169315788071002?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/5778169315788071002/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=5778169315788071002' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/5778169315788071002'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/5778169315788071002'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2008/07/mobile-devices-connecting-physicians.html' title='Mobile Devices: Connecting Physicians and Pharma'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-339760070915950093</id><published>2008-07-18T16:40:00.005-05:00</published><updated>2008-09-11T09:39:21.516-05:00</updated><title type='text'>Patient Journey Marketing™ and the Power of Video</title><content type='html'>Date:7/8/2008&lt;br /&gt;Length: 00:17:52&lt;br /&gt;Size: 8.32MB&lt;br /&gt;Thought Leader: Liz Kay, VP, Account Services, Healthcare Practice, Cramer&lt;br /&gt;&lt;br /&gt;In this episode, Liz Kay discusses the use of online video as an effective and interactive medium for patient communications.Whitepaper: How Patient Journey Marketing™ delivers more value to your customers and your bottom line&lt;br /&gt;&lt;br /&gt;&lt;a onclick="return winControl(href, '450', '400', 'podcasts')" href="http://www.pharmavoice.com/webcasts/kay/0708-Cramer-edit2-mixed.mp3"&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmalinx.com/Cramer"&gt;Download Related White Paper&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-339760070915950093?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/339760070915950093/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=339760070915950093' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/339760070915950093'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/339760070915950093'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2008/07/patient-journey-marketing-and-power-of.html' title='Patient Journey Marketing™ and the Power of Video'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-2337844134618592532</id><published>2008-07-18T16:39:00.002-05:00</published><updated>2008-09-12T08:31:43.784-05:00</updated><title type='text'>Improving Clinical Operations at AstraZeneca</title><content type='html'>Date:6/27/2008&lt;br /&gt;Length: 00:16:09&lt;br /&gt;Size: 7.39MB&lt;br /&gt;Thought Leader: Karen Gotting-Smith, Ph.D. VP, Business Performance and Continuous Improvement, AstraZeneca Pharmaceuticals&lt;br /&gt;&lt;br /&gt;Taren Grom, CoFounder and Editor-in-Chief of PharmaVOICE talks with Dr. Gotting-Smith about current market factors driving change in clinical operations, outsourcing considerations, new technologies and advances in data management.&lt;br /&gt;&lt;br /&gt;&lt;a onclick="return winControl(href, '450', '400', 'podcasts')" href="http://stage.pharmavoice.com/webcasts/az/AZ-edit1-mixed3.mp3"&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-2337844134618592532?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/2337844134618592532/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=2337844134618592532' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/2337844134618592532'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/2337844134618592532'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2008/07/improving-clinical-operations-at.html' title='Improving Clinical Operations at AstraZeneca'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-8255866133603633657</id><published>2008-07-18T16:37:00.002-05:00</published><updated>2008-09-12T08:33:47.764-05:00</updated><title type='text'>A Dual-Degree MSPharm/MBA Online Program for Life-Sciences Professionals</title><content type='html'>Date:6/16/2008&lt;br /&gt;Length: 00:09:10&lt;br /&gt;Size: 4.2MB&lt;br /&gt;Thought Leader: David B. Brushwood, R.Ph., J.D., Professor of Pharmaceutical Outcomes and Policy, University of Florida&lt;br /&gt;&lt;br /&gt;In this episode, Professor Brushwood provides an overview of a new online dual-degree program: a Master of Science in Pharmacy degree from the University of Florida and a Master of Business Administration from Stetson University. He discusses the benefits of the dynamic dual-degree, the program structure, the advantages of an online program, and admission requirements.&lt;br /&gt;&lt;br /&gt;&lt;a onclick="return winControl(href, '450', '400', 'podcasts')" href="http://stage.pharmavoice.com/webcasts/uflorida/UFlorida-edit1-mixed.mp3"&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-8255866133603633657?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/8255866133603633657/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=8255866133603633657' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/8255866133603633657'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/8255866133603633657'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2008/07/dual-degree-mspharmmba-online-program.html' title='A Dual-Degree MSPharm/MBA Online Program for Life-Sciences Professionals'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-611294192137457312</id><published>2008-07-18T16:36:00.001-05:00</published><updated>2008-09-12T08:35:33.890-05:00</updated><title type='text'>Stiefel’s Dedication to Corporate Philanthropy</title><content type='html'>Date: 6/19/2008&lt;br /&gt;Length: 00:10:59&lt;br /&gt;Size: 5.09MB&lt;br /&gt;Thought Leader: Lyra Myers, Senior Global Category Manager, Stiefel Laboratories&lt;br /&gt;&lt;br /&gt;In this episode, Taren Grom, Editor of PharmaVOICE, speaks with Lyra Myers about Stiefel’s many activities in corporate philanthropy, as well as her personal commitment to worthy causes.&lt;br /&gt;&lt;a onclick="return winControl(href, '450', '400', 'podcasts')" href="http://stage.pharmavoice.com/webcasts/stiefel/stiefel0608-edit2-mixed.mp3"&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-611294192137457312?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/611294192137457312/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=611294192137457312' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/611294192137457312'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/611294192137457312'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2008/07/stiefels-dedication-to-corporate.html' title='Stiefel’s Dedication to Corporate Philanthropy'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-1156549247411142028</id><published>2008-07-18T16:35:00.001-05:00</published><updated>2008-09-12T08:36:28.205-05:00</updated><title type='text'>Amgen’s Commitment to Philanthropy</title><content type='html'>Date:6/13/2008&lt;br /&gt;Length: 00:08:46&lt;br /&gt;Size: 4.01MB&lt;br /&gt;Thought Leader: Eduardo Cetlin, Senior Manager of Corporate Contributions, Amgen&lt;br /&gt;&lt;br /&gt;In this special episode, Taren Grom, Editor of PharmaVOICE, speaks with Eduardo Cetlin, who discusses the Amgen Foundation, how Amgen encourages employees to become involved in volunteerism, his favorite service endeavors, and the overall goal of Amgen's philanthropic efforts.&lt;br /&gt;&lt;br /&gt;&lt;a onclick="return winControl(href, '450', '400', 'podcasts')" href="http://stage.pharmavoice.com/webcasts/amgen/amgen0608-edit2-mixed.mp3"&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-1156549247411142028?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/1156549247411142028/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=1156549247411142028' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/1156549247411142028'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/1156549247411142028'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2008/07/amgens-commitment-to-philanthropy.html' title='Amgen’s Commitment to Philanthropy'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-4129940339626268994</id><published>2008-07-18T16:32:00.002-05:00</published><updated>2008-09-12T08:37:31.812-05:00</updated><title type='text'>A Personal Dedication to Volunteerism and Mentoring</title><content type='html'>Date:6/13/2008&lt;br /&gt;Length: 00:12:44&lt;br /&gt;Size: 5.82MB&lt;br /&gt;Thought Leader: Sherrie Pietranico, Ph.D., Research Leader, Roche&lt;br /&gt;&lt;br /&gt;In this special episode, Taren Grom, Editor of PharmaVOICE, speaks with Dr. Pietranico about her volunteer activities educating elementary school children about science, and how the Roche internship program helped one student become a successful scientist in the pharmaceutical industry.&lt;br /&gt;&lt;br /&gt;&lt;a onclick="return winControl(href, '450', '400', 'podcasts')" href="http://stage.pharmavoice.com/webcasts/roche/roche0608-edit1-mixed.mp3"&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-4129940339626268994?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/4129940339626268994/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=4129940339626268994' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/4129940339626268994'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/4129940339626268994'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2008/07/personal-dedication-to-volunteerism-and.html' title='A Personal Dedication to Volunteerism and Mentoring'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-8683618780961424321</id><published>2008-07-18T16:30:00.003-05:00</published><updated>2008-09-12T08:38:32.845-05:00</updated><title type='text'>Making Pharmacovigilance Work: Key steps for implementing a proactive, business-critical safety model</title><content type='html'>Date: 6/5/2008&lt;br /&gt;Length: 00:06:39&lt;br /&gt;Size: 3.04MB&lt;br /&gt;&lt;br /&gt;Thought Leader: Uwe Maennl, M.D., Ph.D., VP and Worldwide Head of Pharmacovigilance, PAREXEL International and Gadi Saarony, Corporate VP and Worldwide Head, PAREXEL Consulting&lt;br /&gt;&lt;br /&gt;In this episode, Dr. Maennl and Mr. Saarony discuss a new safety model for pharmacovigilance, including risk management, key stakeholders, and performance benchmarks to this new approach.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://stage.pharmavoice.com/webcasts/parexel/parexel-vpodcast-mixed.mp3" mp3="'%2Fwebcasts%2Fparexel%2Fparexel-vpodcast-mixed.mp3&amp;amp;transcript="&gt;Play Podcast &lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-8683618780961424321?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/8683618780961424321/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=8683618780961424321' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/8683618780961424321'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/8683618780961424321'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2008/07/making-pharmacovigilance-work-key-steps.html' title='Making Pharmacovigilance Work: Key steps for implementing a proactive, business-critical safety model'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-6246889947929906116</id><published>2008-06-03T12:31:00.005-05:00</published><updated>2008-09-12T08:39:50.922-05:00</updated><title type='text'>Redefining the CRO</title><content type='html'>Date: 5/7/2008&lt;br /&gt;Length: 00:13:29&lt;br /&gt;Size: 6.17MB&lt;br /&gt;&lt;br /&gt;Thought Leader: Bob Burford Ph.D., Managing Director, Aptuit Consulting&lt;br /&gt;&lt;br /&gt;In this episode, we discuss the relationship between drug developers and CROs, including current market conditions, the changing needs of drug developers, how to choose an outsourcing provider, expectations of a CRO, and the future of this important relationship.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://stage.pharmavoice.com/webcasts/burford/aptuit-burford1-mixed.mp3"&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-6246889947929906116?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/6246889947929906116/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=6246889947929906116' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/6246889947929906116'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/6246889947929906116'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2008/06/redefining-cro.html' title='Redefining the CRO'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-4730179869712663936</id><published>2008-06-03T12:29:00.003-05:00</published><updated>2008-09-12T08:41:19.785-05:00</updated><title type='text'>Counter-Launch Planning: Pre-empting and Protecting Against Competitive Product Launches</title><content type='html'>Date: 5/6/2008&lt;br /&gt;Length: 00:10:33&lt;br /&gt;Size: 4.83MB&lt;br /&gt;&lt;br /&gt;Thought Leader: Stan Bernard, M.D., MBA, President, Bernard Associates LLC&lt;br /&gt;&lt;br /&gt;Dr. Bernard discusses the underutilized concept of Counter Launch Planning (CLP) for protecting an established brand, including what it is, why it's important, who participates in the process, how it differs from traditional marketing and war games, and finally, important execution considerations.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://stage.pharmavoice.com/webcasts/bernard/Bernard-Podcast2-edit1-mixed.mp3"&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-4730179869712663936?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/4730179869712663936/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=4730179869712663936' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/4730179869712663936'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/4730179869712663936'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2008/06/counter-launch-planning-pre-empting-and.html' title='Counter-Launch Planning: Pre-empting and Protecting Against Competitive Product Launches'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-3781560820281119857</id><published>2008-06-03T12:26:00.005-05:00</published><updated>2008-09-12T08:42:52.745-05:00</updated><title type='text'>Precommercial Marketing and Planning: Securing Future Success through Meaningful Differentiation</title><content type='html'>Date: 4/30/2008&lt;br /&gt;Length: 00:10:58&lt;br /&gt;Size: 5.02MB&lt;br /&gt;&lt;br /&gt;Thought Leader: Laurie Lucas, Founder and Principal, L3 Healthcare Marketing LLC&lt;br /&gt;&lt;br /&gt;This Podcast covers several issues related to starting the marketing sequence earlier in the development cycle, including the differences between precommercial marketing and traditional product marketing, who the stakeholders are, what the necessary activities are, and some best practices for these activities.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://stage.pharmavoice.com/webcasts/lucas/L3-2-edit1-mixed.mp3"&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-3781560820281119857?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/3781560820281119857/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=3781560820281119857' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/3781560820281119857'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/3781560820281119857'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2008/06/precommercial-marketing-and-planning.html' title='Precommercial Marketing and Planning: Securing Future Success through Meaningful Differentiation'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-6013687236061336964</id><published>2008-05-08T07:20:00.001-05:00</published><updated>2008-09-12T08:45:00.891-05:00</updated><title type='text'>Making it Stick – How Can Patient Education Really Make a Difference</title><content type='html'>Date: 4/30/2008&lt;br /&gt;Length: 00:11:50&lt;br /&gt;Size: 5.42MB&lt;br /&gt;&lt;br /&gt;Thought Leaders: Dr. Stanley Wulf, Chief Medical Officer, InfoMedics, and Ray Bullman, Executive VP of NCPIE (National Council on Patient Information and Education)&lt;br /&gt;&lt;br /&gt;This Podcast covers several key issues related to patient education and patient adherence, including who the key players are, what they can do to improve patient education, and what the pharmaceutical companies can do to raise the effectiveness of patient education.&lt;br /&gt;&lt;br /&gt;&lt;a onclick="return winControl(href, '450', '400', 'podcasts')" href="http://stage.pharmavoice.com/webcasts/infomedics/infomedics5-edit1-mixed.mp3"&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-6013687236061336964?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/6013687236061336964/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=6013687236061336964' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/6013687236061336964'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/6013687236061336964'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2008/05/making-it-stick-how-can-patient.html' title='Making it Stick – How Can Patient Education Really Make a Difference'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-7573550074576152425</id><published>2008-05-08T07:19:00.002-05:00</published><updated>2008-09-12T08:46:24.685-05:00</updated><title type='text'>Late-Phase Research Success: Leveraging Secondary Data</title><content type='html'>Date: 4/28/2008&lt;br /&gt;Length: 00:16:02&lt;br /&gt;Size: 7.34MB&lt;br /&gt;&lt;br /&gt;Thought Leader: Cyndi Verst, Pharm.D., M.S., Senior VP, Global Late Phase, i3 InnovusThis Podcast covers the benefits of blending scientific and commercial objectives in late-phase research — saving time and money — the use of specialized data assets, the challenges of leveraging secondary data assets, and what is in store for late-phase research in the near future.&lt;br /&gt;&lt;br /&gt;&lt;a onclick="return winControl(href, '450', '400', 'podcasts')" href="http://stage.pharmavoice.com/webcasts/i3/i3-edit1-mixed.mp3"&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-7573550074576152425?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/7573550074576152425/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=7573550074576152425' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/7573550074576152425'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/7573550074576152425'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2008/05/late-phase-research-success-leveraging.html' title='Late-Phase Research Success: Leveraging Secondary Data'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-7403050293696953335</id><published>2008-05-08T07:17:00.003-05:00</published><updated>2008-09-12T08:47:31.653-05:00</updated><title type='text'>Enhancing Global Market Access Strategies with Named Patient Programs</title><content type='html'>Date: 4/23/2008&lt;br /&gt;Length: 00:12:14&lt;br /&gt;Size: 5.60MB&lt;br /&gt;&lt;br /&gt;Thought Leaders: John Lagus, VP of Business and Corporate Development, IDIS&lt;br /&gt;&lt;br /&gt;This final installment in a three-part series covers how named patient programs can be used for market development, assist with regulatory challenges, address reimbursement issues, and develop key opinion leaders, and more.&lt;br /&gt;&lt;br /&gt;&lt;a onclick="return winControl(href, '450', '400', 'podcasts')" href="http://stage.pharmavoice.com/webcasts/lagus/IDIS3-edit1-mixed.mp3"&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;Free Whitepaper Download: "Enhancing Global Market Access Strategies with Named Patient Programs"&lt;br /&gt;&lt;a href="http://www.idispharma.com/marketaccess"&gt;Download RelatedWhite Paper&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-7403050293696953335?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/7403050293696953335/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=7403050293696953335' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/7403050293696953335'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/7403050293696953335'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2008/05/enhancing-global-market-access.html' title='Enhancing Global Market Access Strategies with Named Patient Programs'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-3167783013071497914</id><published>2008-05-08T07:15:00.004-05:00</published><updated>2008-09-12T10:28:10.522-05:00</updated><title type='text'>The Future of Pharma CRM</title><content type='html'>Date: 4/22/2008&lt;br /&gt;Length: 00:15:43&lt;br /&gt;Size: 7.19MB&lt;br /&gt;&lt;br /&gt;Thought Leader: Matt Wallach, VP Sales and Marketing, Verticals onDemand, Inc.&lt;br /&gt;&lt;br /&gt;This podcast covers the changing pharmaceutical sales and marketing model and the tools and solutions that are needed to shape the future of salesforces.&lt;br /&gt;&lt;br /&gt;&lt;a onclick="return winControl(href, '450', '400', 'podcasts')" href="http://stage.pharmavoice.com/webcasts/vod/VOD-edit2-mixed.mp3"&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;Free Whitepaper Download: "Getting SaaSy In Pharma: How SaaS CRM Technology Today's Beleaguered Pharmaceutical Companies."&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/pdfs/whitepapers/VerticalsOD/SaaSWhitePaper.pdf"&gt;Download Related White Paper&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-3167783013071497914?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/3167783013071497914/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=3167783013071497914' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/3167783013071497914'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/3167783013071497914'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2008/05/future-of-pharma-crm.html' title='The Future of Pharma CRM'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-3775592821930794590</id><published>2008-05-08T07:13:00.003-05:00</published><updated>2008-09-12T08:49:35.071-05:00</updated><title type='text'>Silo Busting – New Approaches to Brand Development</title><content type='html'>Date: 4/2/2008&lt;br /&gt;Length: 00:09:13&lt;br /&gt;Size: 4.21MB&lt;br /&gt;&lt;br /&gt;Event Representative: Camille DeSantis, BS, MT (ASCP), Copresident &amp;amp; Managing Partner, Brand Strategy &amp;amp; Client Services, Guard Dog Brand Development LLC&lt;br /&gt;&lt;br /&gt;This Podcast covers how brand development agencies and life-sciences companies can partner to achieve optimal results, including breaking down the silos between disciplines. We also cover market research and brand identity ROI, and how to handle soft measurables. And, finally, Ms. DeSantis provides three best practices that can be employed to improve brand value through communications.&lt;br /&gt;&lt;br /&gt;&lt;a onclick="return winControl(href, '450', '400', 'podcasts')" href="http://stage.pharmavoice.com/webcasts/desantis/guard-dog-edit1-mixed.mp3" mp3="'%2Fwebcasts%2Fdesantis%2Fguard-dog-edit1-mixed.mp3&amp;amp;transcript="&gt;Play Podcast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-3775592821930794590?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/3775592821930794590/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=3775592821930794590' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/3775592821930794590'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/3775592821930794590'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2008/05/silo-busting-new-approaches-to-brand.html' title='Silo Busting – New Approaches to Brand Development'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-29058079.post-8266609679372123901</id><published>2008-04-01T08:44:00.003-05:00</published><updated>2008-04-01T09:08:46.277-05:00</updated><title type='text'>Training Seminar: Medical Education for Pharmaceutical Professionals: Information, May 6, 2008</title><content type='html'>&lt;a href="http://1.bp.blogspot.com/_I1dsu0S3HGc/R_JB416RaeI/AAAAAAAAAGk/hRGN7oYdeAk/s1600-h/umdnj-dual-logo.jpg"&gt;&lt;img id="BLOGGER_PHOTO_ID_5184278565856831970" style="FLOAT: left; MARGIN: 0px 10px 10px 0px; CURSOR: hand" alt="" src="http://1.bp.blogspot.com/_I1dsu0S3HGc/R_JB416RaeI/AAAAAAAAAGk/hRGN7oYdeAk/s400/umdnj-dual-logo.jpg" border="0" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;Date: 3/20/2008&lt;br /&gt;Length: 00:06:37&lt;br /&gt;Size: 3.03MB&lt;br /&gt;&lt;br /&gt;Event Representative: Dr. Paul M. Krueger, Associate Dean for Academic Affairs, at the UMDNJ School of Osteopathic Medicine in New Jersey&lt;br /&gt;&lt;br /&gt;Dr. Krueger provides an overview of an upcoming, day-long seminar focused on the diagnosis and treatment of medical disorders: Fundamentals of Clinical Practice. This is the first in a series of instructional forums called Medical Education for Pharmaceutical Professionals, also known as MEPP. The first seminar will be held May 6, 2008, in New Jersey.&lt;br /&gt;&lt;br /&gt;For seminar information and registration, &lt;a href="http://som.umdnj.edu/mepp"&gt;click here&lt;/a&gt;.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/podcasts/UMDNJ/UMDNJ-edit1mixed.mp3"&gt;Play Full Podcast&lt;br /&gt;&lt;/a&gt;&lt;br /&gt;For more information on how you can be featured in a podcast, contact Dan Limbach at &lt;a href="mailto:dlimbach@pharmavoice.com"&gt;dlimbach@pharmavoice.com&lt;/a&gt; or call him at (847) 594-0157.&lt;br /&gt;&lt;a href="http://www.pharmavoice.com/podcasts/UMDNJ/UMDNJ-edit1mixed.mp3"&gt;&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/29058079-8266609679372123901?l=pvpodcasts.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pvpodcasts.blogspot.com/feeds/8266609679372123901/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=29058079&amp;postID=8266609679372123901' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/8266609679372123901'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/29058079/posts/default/8266609679372123901'/><link rel='alternate' type='text/html' href='http://pvpodcasts.blogspot.com/2008/04/training-seminar-medical-education-for.html' title='Training Seminar: Medical Education for Pharmaceutical Professionals: Information, May 6, 2008'/><author><name>Dan Limbach</name><uri>http://www.blogger.com/profile/03155480412902133621</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://static.flickr.com/34/94656589_03b06c2ff0_m.jpg'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://1.bp.blogspot.com/_I1dsu0S3HGc/R_JB416RaeI/AAAAAAAAAGk/hRGN7oYdeAk/s72-c/umdnj-dual-logo.jpg' height='72' width='72'/><thr:total>0</thr:total></entry></feed>
